Dataset Viewer
Question
stringlengths 946
4.63k
| Answer
stringlengths 60
693
| label
int64 0
1
| class_hall
stringclasses 2
values | prompt
stringlengths 1.09k
4.85k
| input_ids
sequencelengths 1.15k
1.15k
| attention_mask
sequencelengths 1.15k
1.15k
|
|---|---|---|---|---|---|---|
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. To date, no adequate data are available on direct comparison of the efficacy of levocetirizine, a recently approved histamine1-antihistamine, with that of a leukotriene antagonist in the treatment of seasonal allergic rhinitis (SAR) symptoms. To compare the efficacy of therapeutic doses of 5 mg of levocetirizine and 10 mg of montelukast in ragweed sensitized patients. A randomized, double-blind, placebo-controlled, parallel-group study was conducted between July and October 2006. Symptomatic patients with SAR were exposed to ragweed pollen under controlled conditions in an environmental exposure chamber for 4 to 5 hours after treatment with 5 mg of levocetirizine, 10 mg of montelukast, or matched placebo on 2 consecutive days. The mean change from baseline in pollen-induced rhinitis symptoms, expressed as a major symptoms complex (MSC) score (sum of scores for rhinorrhea, itchy nose, sniffles, nose blows, sneezes, and watery eyes), in period 1 (first 5 hours after first drug intake) was the primary efficacy outcome. A total of 611 patients were screened, of whom 403 were randomized to receive treatment (102 placebo, 152 levocetirizine, and 149 montelukast). The MSC score in period 1 was progressively decreased to a significantly greater extent in the levocetirizine group compared with the montelukast and placebo groups (adjusted mean differences, -2.18 [95% confidence interval, -3.35 to -1.01; P < .001] and -2.22 [95% confidence interval, -3.51 to -0.92; P < .001] for levocetirizine vs montelukast and vs placebo, respectively). The effect of 10 mg of montelukast was not significantly different compared with placebo. Levocetirizine also achieved a significantly faster onset of action within 2.5 hours of administration. Both products were well tolerated. This study in an environmental exposure chamber confirms the therapeutic efficacy of 5 mg of levocetirizine in improving symptoms of SAR, which was superior to 10 mg of montelukast. Output: | {'conditions': 'Conscious Sedation', 'interventions': 'Drug: Paracetamol.'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Efficacy comparison of levocetirizine vs montelukast in ragweed sensitized patients. To date, no adequate data are available on direct comparison of the efficacy of levocetirizine, a recently approved histamine1-antihistamine, with that of a leukotriene antagonist in the treatment of seasonal allergic rhinitis (SAR) symptoms. To compare the efficacy of therapeutic doses of 5 mg of levocetirizine and 10 mg of montelukast in ragweed sensitized patients. A randomized, double-blind, placebo-controlled, parallel-group study was conducted between July and October 2006. Symptomatic patients with SAR were exposed to ragweed pollen under controlled conditions in an environmental exposure chamber for 4 to 5 hours after treatment with 5 mg of levocetirizine, 10 mg of montelukast, or matched placebo on 2 consecutive days. The mean change from baseline in pollen-induced rhinitis symptoms, expressed as a major symptoms complex (MSC) score (sum of scores for rhinorrhea, itchy nose, sniffles, nose blows, sneezes, and watery eyes), in period 1 (first 5 hours after first drug intake) was the primary efficacy outcome. A total of 611 patients were screened, of whom 403 were randomized to receive treatment (102 placebo, 152 levocetirizine, and 149 montelukast). The MSC score in period 1 was progressively decreased to a significantly greater extent in the levocetirizine group compared with the montelukast and placebo groups (adjusted mean differences, -2.18 [95% confidence interval, -3.35 to -1.01; P < .001] and -2.22 [95% confidence interval, -3.51 to -0.92; P < .001] for levocetirizine vs montelukast and vs placebo, respectively). The effect of 10 mg of montelukast was not significantly different compared with placebo. Levocetirizine also achieved a significantly faster onset of action within 2.5 hours of administration. Both products were well tolerated. This study in an environmental exposure chamber confirms the therapeutic efficacy of 5 mg of levocetirizine in improving symptoms of SAR, which was superior to 10 mg of montelukast. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Conscious Sedation', 'interventions': 'Drug: Paracetamol.'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
192127,
11482,
576,
709,
214099,
487,
9314,
622,
5135,
43498,
37360,
897,
575,
32486,
27268,
17387,
39620,
6022,
235265,
139,
1469,
3209,
235269,
793,
17246,
1423,
708,
2506,
611,
3280,
11482,
576,
573,
43391,
576,
709,
214099,
487,
9314,
622,
235269,
476,
7378,
11559,
211762,
235274,
235290,
2236,
6702,
20724,
235269,
675,
674,
576,
476,
41954,
100832,
1471,
101307,
575,
573,
5158,
576,
32132,
58699,
69022,
17945,
591,
60577,
235275,
12447,
235265,
1887,
12711,
573,
43391,
576,
37580,
33579,
576,
235248,
235308,
11606,
576,
709,
214099,
487,
9314,
622,
578,
235248,
235274,
235276,
11606,
576,
43498,
37360,
897,
575,
32486,
27268,
17387,
39620,
6022,
235265,
586,
74016,
235269,
4199,
235290,
58122,
235269,
70061,
235290,
41789,
235269,
14255,
235290,
3620,
3320,
729,
12028,
1865,
4707,
578,
5424,
235248,
235284,
235276,
235276,
235318,
235265,
27767,
511,
5560,
6022,
675,
48532,
1049,
15401,
577,
32486,
27268,
54778,
1362,
15081,
4202,
575,
671,
10868,
12793,
20864,
604,
235248,
235310,
577,
235248,
235308,
3763,
1452,
5158,
675,
235248,
235308,
11606,
576,
709,
214099,
487,
9314,
622,
235269,
235248,
235274,
235276,
11606,
576,
43498,
37360,
897,
235269,
689,
31128,
70061,
611,
235248,
235284,
31185,
2705,
235265,
714,
2714,
2669,
774,
31472,
575,
54778,
235290,
30836,
69022,
17945,
12447,
235269,
10862,
685,
476,
3885,
12447,
5766,
591,
55894,
235275,
7716,
591,
1882,
576,
16382,
604,
69022,
143787,
235269,
139347,
16482,
235269,
73931,
982,
235269,
16482,
47351,
235269,
92804,
6758,
235269,
578,
108777,
4628,
823,
575,
4037,
235248,
235274,
591,
4878,
235248,
235308,
3763,
1452,
1370,
10471,
25739,
235275,
729,
573,
7920,
43391,
17526,
235265,
586,
3051,
576,
235248,
235318,
235274,
235274,
6022,
1049,
70430,
235269,
576,
7624,
235248,
235310,
235276,
235304,
1049,
74016,
577,
6427,
5158,
591,
235274,
235276,
235284,
70061,
235269,
235248,
235274,
235308,
235284,
709,
214099,
487,
9314,
622,
235269,
578,
235248,
235274,
235310,
235315,
43498,
37360,
897,
846,
714,
73160,
7716,
575,
4037,
235248,
235274,
729,
80470,
25339,
577,
476,
12879,
6561,
10617,
575,
573,
709,
214099,
487,
9314,
622,
2778,
7631,
675,
573,
43498,
37360,
897,
578,
70061,
5452,
591,
83414,
2714,
10216,
235269,
728,
235284,
235265,
235274,
235321,
892,
235315,
235308,
235358,
12087,
15133,
235269,
728,
235304,
235265,
235304,
235308,
577,
728,
235274,
235265,
235276,
235274,
235289,
596,
968,
954,
235276,
235276,
235274,
235307,
578,
728,
235284,
235265,
235284,
235284,
892,
235315,
235308,
235358,
12087,
15133,
235269,
728,
235304,
235265,
235308,
235274,
577,
728,
235276,
235265,
235315,
235284,
235289,
596,
968,
954,
235276,
235276,
235274,
235307,
604,
709,
214099,
487,
9314,
622,
5135,
43498,
37360,
897,
578,
5135,
70061,
235269,
11235,
846,
714,
4232,
576,
235248,
235274,
235276,
11606,
576,
43498,
37360,
897,
729,
780,
12879,
2167,
7631,
675,
70061,
235265,
1709,
214099,
487,
9314,
622,
1170,
14645,
476,
12879,
13042,
42673,
576,
3105,
2819,
235248,
235284,
235265,
235308,
3763,
576,
11588,
235265,
11553,
3773,
1049,
1578,
82277,
235265,
1417,
3320,
575,
671,
10868,
12793,
20864,
54759,
573,
37580,
43391,
576,
235248,
235308,
11606,
576,
709,
214099,
487,
9314,
622,
575,
19031,
12447,
576,
48532,
235269,
948,
729,
11257,
577,
235248,
235274,
235276,
11606,
576,
43498,
37360,
897,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
170917,
23996,
673,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
9412,
174485,
5294,
235270,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Hypotonic versus isotonic maintenance fluids after surgery for children: a randomized controlled trial. The objective of this randomized controlled trial was to evaluate the risk of hyponatremia following administration of a isotonic (0.9% saline) compared to a hypotonic (0.45% saline) parenteral maintenance solution (PMS) for 48 hours to postoperative pediatric patients. Surgical patients 6 months to 16 years of age with an expected postoperative stay of >24 hours were eligible. Patients with an uncorrected baseline plasma sodium level abnormality, hemodynamic instability, chronic diuretic use, previous enrollment, and those for whom either hypotonic PMS or isotonic PMS was considered contraindicated or necessary, were excluded. A fully blinded randomized controlled trial was performed. The primary outcome was acute hyponatremia. Secondary outcomes included severe hyponatremia, hypernatremia, adverse events attributable to acute plasma sodium level changes, and antidiuretic hormone levels. A total of 258 patients were enrolled and assigned randomly to receive hypotonic PMS (N = 130) or isotonic PMS (N = 128). Baseline characteristics were similar for the 2 groups. Hypotonic PMS significantly increased the risk of hyponatremia, compared with isotonic PMS (40.8% vs 22.7%; relative risk: 1.82 [95% confidence interval: 1.21-2.74]; P = .004). Admission to the pediatric critical care unit was not an independent risk factor for the development of hyponatremia. Isotonic PMS did not increase the risk of hypernatremia (relative risk: 1.30 [95% confidence interval: 0.30-5.59]; P = .722). Antidiuretic hormone levels and adverse events were not significantly different between the groups. Isotonic PMS is significantly safer than hypotonic PMS in protecting against acute postoperative hyponatremia in children. Output: | {'conditions': 'Hyponatremia|Hypernatremia', 'interventions': 'Drug: 0.9% NaCl|Drug: 0.45%NaCl'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Hypotonic versus isotonic maintenance fluids after surgery for children: a randomized controlled trial. The objective of this randomized controlled trial was to evaluate the risk of hyponatremia following administration of a isotonic (0.9% saline) compared to a hypotonic (0.45% saline) parenteral maintenance solution (PMS) for 48 hours to postoperative pediatric patients. Surgical patients 6 months to 16 years of age with an expected postoperative stay of >24 hours were eligible. Patients with an uncorrected baseline plasma sodium level abnormality, hemodynamic instability, chronic diuretic use, previous enrollment, and those for whom either hypotonic PMS or isotonic PMS was considered contraindicated or necessary, were excluded. A fully blinded randomized controlled trial was performed. The primary outcome was acute hyponatremia. Secondary outcomes included severe hyponatremia, hypernatremia, adverse events attributable to acute plasma sodium level changes, and antidiuretic hormone levels. A total of 258 patients were enrolled and assigned randomly to receive hypotonic PMS (N = 130) or isotonic PMS (N = 128). Baseline characteristics were similar for the 2 groups. Hypotonic PMS significantly increased the risk of hyponatremia, compared with isotonic PMS (40.8% vs 22.7%; relative risk: 1.82 [95% confidence interval: 1.21-2.74]; P = .004). Admission to the pediatric critical care unit was not an independent risk factor for the development of hyponatremia. Isotonic PMS did not increase the risk of hypernatremia (relative risk: 1.30 [95% confidence interval: 0.30-5.59]; P = .722). Antidiuretic hormone levels and adverse events were not significantly different between the groups. Isotonic PMS is significantly safer than hypotonic PMS in protecting against acute postoperative hyponatremia in children. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Hyponatremia|Hypernatremia', 'interventions': 'Drug: 0.9% NaCl|Drug: 0.45%NaCl'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
49461,
115317,
17529,
603,
115317,
10841,
49205,
1452,
15505,
604,
3069,
235292,
476,
74016,
15081,
7856,
235265,
139,
651,
15535,
576,
736,
74016,
15081,
7856,
729,
577,
18739,
573,
5685,
576,
3233,
1255,
482,
196957,
2412,
11588,
576,
476,
603,
115317,
591,
235276,
235265,
235315,
235358,
67201,
235275,
7631,
577,
476,
18818,
10331,
591,
235276,
235265,
235310,
235308,
235358,
67201,
235275,
3092,
221240,
10841,
4558,
591,
154877,
235275,
604,
235248,
235310,
235321,
3763,
577,
102698,
82405,
6022,
235265,
85264,
6022,
235248,
235318,
4063,
577,
235248,
235274,
235318,
1658,
576,
3911,
675,
671,
5043,
102698,
4692,
576,
1562,
235284,
235310,
3763,
1049,
22075,
235265,
38586,
675,
671,
748,
103436,
31472,
22874,
24566,
2403,
160690,
235269,
15112,
45331,
53055,
235269,
19424,
148230,
802,
1281,
235269,
4509,
49271,
235269,
578,
1941,
604,
7624,
3906,
18818,
10331,
122206,
689,
603,
115317,
122206,
729,
5604,
3044,
102205,
689,
4647,
235269,
1049,
30111,
235265,
586,
7382,
109891,
74016,
15081,
7856,
729,
8261,
235265,
714,
7920,
17526,
729,
21825,
3233,
1255,
482,
196957,
235265,
36269,
18701,
5484,
14586,
3233,
1255,
482,
196957,
235269,
13099,
10138,
196957,
235269,
23289,
5562,
80375,
577,
21825,
22874,
24566,
2403,
4559,
235269,
578,
3258,
543,
711,
802,
42696,
5902,
235265,
586,
3051,
576,
235248,
235284,
235308,
235321,
6022,
1049,
41872,
578,
15696,
36011,
577,
6427,
18818,
10331,
122206,
591,
235300,
589,
235248,
235274,
235304,
235276,
235275,
689,
603,
115317,
122206,
591,
235300,
589,
235248,
235274,
235284,
235321,
846,
91447,
10314,
1049,
3968,
604,
573,
235248,
235284,
5452,
235265,
36663,
115317,
122206,
12879,
6629,
573,
5685,
576,
3233,
1255,
482,
196957,
235269,
7631,
675,
603,
115317,
122206,
591,
235310,
235276,
235265,
235321,
235358,
5135,
235248,
235284,
235284,
235265,
235324,
11542,
8761,
5685,
235292,
235248,
235274,
235265,
235321,
235284,
892,
235315,
235308,
235358,
12087,
15133,
235292,
235248,
235274,
235265,
235284,
235274,
235290,
235284,
235265,
235324,
235310,
1380,
596,
589,
954,
235276,
235276,
235310,
846,
60285,
577,
573,
82405,
9523,
2212,
4982,
729,
780,
671,
9560,
5685,
7435,
604,
573,
3505,
576,
3233,
1255,
482,
196957,
235265,
2125,
115317,
122206,
1498,
780,
4740,
573,
5685,
576,
13099,
10138,
196957,
591,
27846,
5685,
235292,
235248,
235274,
235265,
235304,
235276,
892,
235315,
235308,
235358,
12087,
15133,
235292,
235248,
235276,
235265,
235304,
235276,
235290,
235308,
235265,
235308,
235315,
1380,
596,
589,
954,
235324,
235284,
235284,
846,
9857,
543,
711,
802,
42696,
5902,
578,
23289,
5562,
1049,
780,
12879,
2167,
1865,
573,
5452,
235265,
2125,
115317,
122206,
603,
12879,
38873,
1178,
18818,
10331,
122206,
575,
30356,
2691,
21825,
102698,
3233,
1255,
482,
196957,
575,
3069,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
13611,
1255,
482,
196957,
235371,
38954,
10138,
196957,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
235248,
235276,
235265,
235315,
235358,
94288,
235371,
55031,
235292,
235248,
235276,
235265,
235310,
235308,
235358,
111929,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. Insulin resistance is a predictor of poor response to peginterferon/ribavirin in patients infected with the chronic hepatitis C virus (HCV). There are no data on direct-acting antivirals. This exploratory analysis assessed the effect of metabolic factors and insulin resistance, measured by homoeostatic model assessment (HOMA), on virological response to telaprevir in Study C208. Overall, 161 HCV genotype 1-infected, treatment-naïve patients received 12 weeks of telaprevir plus peginterferon/ribavirin, then 12/36 weeks of peginterferon/ribavirin depending on on-treatment response criteria. The prognostic significance of several factors, including HOMA-insulin resistance (HOMA-IR), on virological response at weeks 4 and 12, end of treatment and 24 weeks after treatment was explored by multiple regression analysis. Baseline HOMA-IR data were available for 147 patients; baseline characteristics were consistent with the overall population. Baseline HOMA-IR <2, 2-4 and >4 was seen in 54%, 30% and 16% of patients, respectively. Neither response rates (any time point) nor week 4 viral load decline were significantly influenced by baseline HOMA-IR. In multivariate analyses, fibrosis stage and low-density lipoprotein cholesterol level were predictive of sustained virological response (OR 0.47 and 1.02, respectively). After the end of treatment, HOMA-IR was significantly lower in patients with sustained virological response than in those without (0.61 vs 1.34 for relapsers and 1.15 for non-responders; p<0.05). In this study, baseline HOMA-IR was not predictive of virological response to telaprevir in HCV genotype 1-infected, treatment-naïve patients, while sustained virological response was associated with improved HOMA-IR. These results suggest that metabolic factors and insulin resistance do not have a significant effect on telaprevir-based treatment efficacy. Output: | {'conditions': 'Hepatitis C, Chronic', 'interventions': 'Drug: Telaprevir'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1. Insulin resistance is a predictor of poor response to peginterferon/ribavirin in patients infected with the chronic hepatitis C virus (HCV). There are no data on direct-acting antivirals. This exploratory analysis assessed the effect of metabolic factors and insulin resistance, measured by homoeostatic model assessment (HOMA), on virological response to telaprevir in Study C208. Overall, 161 HCV genotype 1-infected, treatment-naïve patients received 12 weeks of telaprevir plus peginterferon/ribavirin, then 12/36 weeks of peginterferon/ribavirin depending on on-treatment response criteria. The prognostic significance of several factors, including HOMA-insulin resistance (HOMA-IR), on virological response at weeks 4 and 12, end of treatment and 24 weeks after treatment was explored by multiple regression analysis. Baseline HOMA-IR data were available for 147 patients; baseline characteristics were consistent with the overall population. Baseline HOMA-IR <2, 2-4 and >4 was seen in 54%, 30% and 16% of patients, respectively. Neither response rates (any time point) nor week 4 viral load decline were significantly influenced by baseline HOMA-IR. In multivariate analyses, fibrosis stage and low-density lipoprotein cholesterol level were predictive of sustained virological response (OR 0.47 and 1.02, respectively). After the end of treatment, HOMA-IR was significantly lower in patients with sustained virological response than in those without (0.61 vs 1.34 for relapsers and 1.15 for non-responders; p<0.05). In this study, baseline HOMA-IR was not predictive of virological response to telaprevir in HCV genotype 1-infected, treatment-naïve patients, while sustained virological response was associated with improved HOMA-IR. These results suggest that metabolic factors and insulin resistance do not have a significant effect on telaprevir-based treatment efficacy. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Hepatitis C, Chronic', 'interventions': 'Drug: Telaprevir'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
194447,
10942,
578,
3590,
577,
8175,
750,
478,
2340,
2755,
1099,
778,
610,
870,
477,
6073,
578,
20791,
782,
70156,
575,
5158,
235290,
168732,
6022,
28757,
675,
157692,
94765,
235248,
235274,
235265,
139,
194447,
10942,
603,
476,
91626,
576,
6528,
3590,
577,
1099,
778,
610,
870,
477,
235283,
14544,
782,
70156,
575,
6022,
28757,
675,
573,
19424,
76178,
585,
12369,
591,
235314,
17813,
846,
2456,
708,
793,
1423,
611,
3280,
235290,
50206,
3258,
2340,
1151,
235265,
1417,
114836,
4084,
28234,
573,
4232,
576,
44844,
7549,
578,
37340,
10942,
235269,
11618,
731,
3654,
23512,
170477,
2091,
11449,
591,
235314,
50652,
823,
611,
170899,
3676,
3590,
577,
8175,
750,
478,
2340,
575,
9104,
585,
235284,
235276,
235321,
235265,
30753,
235269,
235248,
235274,
235318,
235274,
157692,
94765,
235248,
235274,
235290,
89380,
235269,
5158,
235290,
556,
236370,
524,
6022,
4956,
235248,
235274,
235284,
5976,
576,
8175,
750,
478,
2340,
2755,
1099,
778,
610,
870,
477,
235283,
14544,
782,
70156,
235269,
1492,
235248,
235274,
235284,
235283,
235304,
235318,
5976,
576,
1099,
778,
610,
870,
477,
235283,
14544,
782,
70156,
13478,
611,
611,
235290,
50898,
3590,
12830,
235265,
714,
116737,
18279,
576,
3757,
7549,
235269,
3359,
640,
50652,
235290,
220658,
10942,
591,
235314,
50652,
235290,
2716,
823,
611,
170899,
3676,
3590,
696,
5976,
235248,
235310,
578,
235248,
235274,
235284,
235269,
1580,
576,
5158,
578,
235248,
235284,
235310,
5976,
1452,
5158,
729,
41316,
731,
6733,
26221,
4084,
235265,
91447,
640,
50652,
235290,
2716,
1423,
1049,
2506,
604,
235248,
235274,
235310,
235324,
6022,
235289,
31472,
10314,
1049,
14097,
675,
573,
8691,
6280,
235265,
91447,
640,
50652,
235290,
2716,
968,
235284,
235269,
235248,
235284,
235290,
235310,
578,
1562,
235310,
729,
3624,
575,
235248,
235308,
235310,
13520,
235248,
235304,
235276,
235358,
578,
235248,
235274,
235318,
235358,
576,
6022,
235269,
11235,
235265,
38017,
3590,
7803,
591,
1385,
1069,
2377,
235275,
4641,
2788,
235248,
235310,
28241,
4412,
19944,
1049,
12879,
26068,
731,
31472,
640,
50652,
235290,
2716,
235265,
878,
103249,
16876,
235269,
94557,
6325,
578,
3178,
235290,
33924,
177682,
45365,
2403,
1049,
64325,
576,
27476,
170899,
3676,
3590,
591,
1045,
235248,
235276,
235265,
235310,
235324,
578,
235248,
235274,
235265,
235276,
235284,
235269,
11235,
846,
4660,
573,
1580,
576,
5158,
235269,
640,
50652,
235290,
2716,
729,
12879,
4581,
575,
6022,
675,
27476,
170899,
3676,
3590,
1178,
575,
1941,
2346,
591,
235276,
235265,
235318,
235274,
5135,
235248,
235274,
235265,
235304,
235310,
604,
5647,
833,
618,
578,
235248,
235274,
235265,
235274,
235308,
604,
2173,
235290,
5270,
618,
235289,
503,
235322,
235276,
235265,
235276,
235308,
846,
878,
736,
3320,
235269,
31472,
640,
50652,
235290,
2716,
729,
780,
64325,
576,
170899,
3676,
3590,
577,
8175,
750,
478,
2340,
575,
157692,
94765,
235248,
235274,
235290,
89380,
235269,
5158,
235290,
556,
236370,
524,
6022,
235269,
2183,
27476,
170899,
3676,
3590,
729,
7059,
675,
12188,
640,
50652,
235290,
2716,
235265,
3766,
3190,
9337,
674,
44844,
7549,
578,
37340,
10942,
749,
780,
791,
476,
4937,
4232,
611,
8175,
750,
478,
2340,
235290,
6576,
5158,
43391,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
70849,
39207,
585,
235269,
28588,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
13763,
750,
478,
2340,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. Many studies have demonstrated that low heart rate variability (HRV) is a risk for high mortality and morbidity in patients with cardiovascular diseases. The primary purpose of the study was to evaluate whether pregabalin improves HRV in patients with diabetes and painful peripheral neuropathy. Resting heart rates were collected by using the LifeShirt System, developed by VivoMetrics (Ventura, Calif), at baseline and at the end of a 4-week intervention of pregabalin or placebo in patients with painful diabetic peripheral neuropathy. Heart rate variability analysis was performed on the collected R-R intervals using the Vivo- VMLA-036-00 3 Logic of the LifeShirt system. Of the 40 patients enrolled in the study, 70% completed the end of 4-week assessments (n = 15 in pregabalin and n = 14 in placebo). Compared with placebo, pregabalin treatment resulted in significant improvement in HRV measured by frequency domain analysis, that is, a reduction in low frequency-high frequency ratio (-1.30 ± 2.89 vs 0.37 ± 0.33, P = 0.03) and power of normalized low frequency (-0.049 ± 0.092 vs 0.0066 ± 0.023, P = 0.02), as well as an increase in power of normalized high frequency (0.039 ± 0.094 vs -0.038 ± 0.066, P = 0.02). Furthermore, pregabalin resulted in greater reduction of pain and symptoms of anxiety and greater improvement of quality of life. The improvement of HRV measures were not correlated with change of those measures. In conclusion, 4-week pregabalin treatment improved HRV in patients with painful diabetic peripheral neuropathy. NCT00573261 (clinicaltrials.gov). Output: | {'conditions': 'Diabetic Neuropathy', 'interventions': 'Drug: Pregabalin|Drug: Placebo'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. Many studies have demonstrated that low heart rate variability (HRV) is a risk for high mortality and morbidity in patients with cardiovascular diseases. The primary purpose of the study was to evaluate whether pregabalin improves HRV in patients with diabetes and painful peripheral neuropathy. Resting heart rates were collected by using the LifeShirt System, developed by VivoMetrics (Ventura, Calif), at baseline and at the end of a 4-week intervention of pregabalin or placebo in patients with painful diabetic peripheral neuropathy. Heart rate variability analysis was performed on the collected R-R intervals using the Vivo- VMLA-036-00 3 Logic of the LifeShirt system. Of the 40 patients enrolled in the study, 70% completed the end of 4-week assessments (n = 15 in pregabalin and n = 14 in placebo). Compared with placebo, pregabalin treatment resulted in significant improvement in HRV measured by frequency domain analysis, that is, a reduction in low frequency-high frequency ratio (-1.30 ± 2.89 vs 0.37 ± 0.33, P = 0.03) and power of normalized low frequency (-0.049 ± 0.092 vs 0.0066 ± 0.023, P = 0.02), as well as an increase in power of normalized high frequency (0.039 ± 0.094 vs -0.038 ± 0.066, P = 0.02). Furthermore, pregabalin resulted in greater reduction of pain and symptoms of anxiety and greater improvement of quality of life. The improvement of HRV measures were not correlated with change of those measures. In conclusion, 4-week pregabalin treatment improved HRV in patients with painful diabetic peripheral neuropathy. NCT00573261 (clinicaltrials.gov). Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Diabetic Neuropathy', 'interventions': 'Drug: Pregabalin|Drug: Placebo'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
36963,
576,
953,
44032,
25028,
611,
3760,
3974,
42358,
575,
6022,
675,
28222,
63799,
178866,
235265,
139,
9691,
6438,
791,
19624,
674,
3178,
3760,
3974,
42358,
591,
12781,
235330,
235275,
603,
476,
5685,
604,
1536,
27470,
578,
119852,
575,
6022,
675,
52138,
16011,
235265,
714,
7920,
6187,
576,
573,
3320,
729,
577,
18739,
4270,
953,
44032,
25028,
38291,
21050,
235330,
575,
6022,
675,
19641,
578,
28222,
45197,
178866,
235265,
13662,
574,
3760,
7803,
1049,
12184,
731,
2177,
573,
6251,
59127,
1479,
235269,
6990,
731,
72814,
39197,
591,
66169,
1908,
235269,
35795,
823,
696,
31472,
578,
696,
573,
1580,
576,
476,
235248,
235310,
235290,
13118,
21683,
576,
953,
44032,
25028,
689,
70061,
575,
6022,
675,
28222,
63799,
45197,
178866,
235265,
14753,
3974,
42358,
4084,
729,
8261,
611,
573,
12184,
625,
235290,
235294,
24580,
2177,
573,
72814,
235290,
744,
128633,
235290,
235276,
235304,
235318,
235290,
235276,
235276,
235248,
235304,
39045,
576,
573,
6251,
59127,
1812,
235265,
4324,
573,
235248,
235310,
235276,
6022,
41872,
575,
573,
3320,
235269,
235248,
235324,
235276,
235358,
8735,
573,
1580,
576,
235248,
235310,
235290,
13118,
37921,
591,
235254,
589,
235248,
235274,
235308,
575,
953,
44032,
25028,
578,
552,
589,
235248,
235274,
235310,
575,
70061,
846,
69083,
675,
70061,
235269,
953,
44032,
25028,
5158,
19499,
575,
4937,
13194,
575,
21050,
235330,
11618,
731,
10474,
11988,
4084,
235269,
674,
603,
235269,
476,
12025,
575,
3178,
10474,
235290,
8538,
10474,
9537,
15958,
235274,
235265,
235304,
235276,
22173,
235248,
235284,
235265,
235321,
235315,
5135,
235248,
235276,
235265,
235304,
235324,
22173,
235248,
235276,
235265,
235304,
235304,
235269,
596,
589,
235248,
235276,
235265,
235276,
235304,
235275,
578,
2384,
576,
45488,
3178,
10474,
15958,
235276,
235265,
235276,
235310,
235315,
22173,
235248,
235276,
235265,
235276,
235315,
235284,
5135,
235248,
235276,
235265,
235276,
235276,
235318,
235318,
22173,
235248,
235276,
235265,
235276,
235284,
235304,
235269,
596,
589,
235248,
235276,
235265,
235276,
235284,
823,
685,
1578,
685,
671,
4740,
575,
2384,
576,
45488,
1536,
10474,
591,
235276,
235265,
235276,
235304,
235315,
22173,
235248,
235276,
235265,
235276,
235315,
235310,
5135,
728,
235276,
235265,
235276,
235304,
235321,
22173,
235248,
235276,
235265,
235276,
235318,
235318,
235269,
596,
589,
235248,
235276,
235265,
235276,
235284,
846,
22174,
235269,
953,
44032,
25028,
19499,
575,
6561,
12025,
576,
4380,
578,
12447,
576,
18579,
578,
6561,
13194,
576,
3614,
576,
1913,
235265,
714,
13194,
576,
21050,
235330,
8292,
1049,
780,
45063,
675,
2669,
576,
1941,
8292,
235265,
878,
13856,
235269,
235248,
235310,
235290,
13118,
953,
44032,
25028,
5158,
12188,
21050,
235330,
575,
6022,
675,
28222,
63799,
45197,
178866,
235265,
128469,
235276,
235276,
235308,
235324,
235304,
235284,
235318,
235274,
591,
72148,
103843,
235265,
9789,
846,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
29919,
40031,
17328,
99260,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
172052,
670,
25028,
235371,
55031,
235292,
232340,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:The effect of erythropoietin on platelet and endothelial activation markers: a prospective trial in healthy volunteers. Erythropoietin (EPO) enhances formation of red blood cells and also affects thrombopoiesis and platelet function. We hypothesized that the effect of EPO may be reflected by changes in thromboxane B2 (TXB2) and endothelial cell function. Six male and six female subjects received recombinant human epoetin alpha (Erypo®) intravenously (300 U/kg). Biomarker levels were assessed at baseline and 4, 24, 48 and 72 hours after infusion. Epoetin alpha increased TXB2 levels by 140%, which reached significance at 48 hours (6.6 ± 5 ng/ml vs. 15 ± 9 ng/ml; p = 0.044) and remained at that level at 72 hours. In line, epoetin alpha increased E-selectin levels by 25% already at 24 hours (39 ± 21 ng/ml vs. 49 ± 26 ng/ml; p < 0.001) which stayed at this level until 72 hours (p < 0.001). The raise in platelet activation markers corresponded to an 88% increase in reticulocyte count (43 ± 10 × 10(9)/l vs. 81 ± 17 × 10(9)/l; p < 0.001) and a 9% increase in platelet count at 72 hours (224 ± 45 × 10(9)/l vs. 244 ± 52 × 10(9)/l; p = 0.005). Thrombomodulin and von Willebrand factor concentrations were not significantly altered by epoetin alpha. Interestingly, gender differences in the baseline levels of E-selectin and thrombomodulin were observed. E-selectin and thrombomodulin levels were doubled in men compared to women (51 ± 24 and 28 ± 10 ng/ml; p = 0.025 and 30 ± 5 ng/ml vs. 16 ± 5 ng/ml; p = 0.002, respectively). EPO increases TXB2 serum levels and soluble E-selectin. Further studies are needed to investigate whether these markers might be useful for estimation of thromboembolic risk during EPO-therapy and whether inhibition of thromboxane formation may lower thrombotic complications during EPO treatment: NCT01392612. Output: | {'conditions': 'Type I Hypersensitivity|Induction Phase', 'interventions': 'Drug: Pylera (Bismuth subcitrate potassium, metronidazole, tetracycline) given in combination with omeprazole'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:The effect of erythropoietin on platelet and endothelial activation markers: a prospective trial in healthy volunteers. Erythropoietin (EPO) enhances formation of red blood cells and also affects thrombopoiesis and platelet function. We hypothesized that the effect of EPO may be reflected by changes in thromboxane B2 (TXB2) and endothelial cell function. Six male and six female subjects received recombinant human epoetin alpha (Erypo®) intravenously (300 U/kg). Biomarker levels were assessed at baseline and 4, 24, 48 and 72 hours after infusion. Epoetin alpha increased TXB2 levels by 140%, which reached significance at 48 hours (6.6 ± 5 ng/ml vs. 15 ± 9 ng/ml; p = 0.044) and remained at that level at 72 hours. In line, epoetin alpha increased E-selectin levels by 25% already at 24 hours (39 ± 21 ng/ml vs. 49 ± 26 ng/ml; p < 0.001) which stayed at this level until 72 hours (p < 0.001). The raise in platelet activation markers corresponded to an 88% increase in reticulocyte count (43 ± 10 × 10(9)/l vs. 81 ± 17 × 10(9)/l; p < 0.001) and a 9% increase in platelet count at 72 hours (224 ± 45 × 10(9)/l vs. 244 ± 52 × 10(9)/l; p = 0.005). Thrombomodulin and von Willebrand factor concentrations were not significantly altered by epoetin alpha. Interestingly, gender differences in the baseline levels of E-selectin and thrombomodulin were observed. E-selectin and thrombomodulin levels were doubled in men compared to women (51 ± 24 and 28 ± 10 ng/ml; p = 0.025 and 30 ± 5 ng/ml vs. 16 ± 5 ng/ml; p = 0.002, respectively). EPO increases TXB2 serum levels and soluble E-selectin. Further studies are needed to investigate whether these markers might be useful for estimation of thromboembolic risk during EPO-therapy and whether inhibition of thromboxane formation may lower thrombotic complications during EPO treatment: NCT01392612. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Type I Hypersensitivity|Induction Phase', 'interventions': 'Drug: Pylera (Bismuth subcitrate potassium, metronidazole, tetracycline) given in combination with omeprazole'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
651,
4232,
576,
146230,
19573,
6565,
473,
611,
116631,
578,
92757,
22525,
33334,
235292,
476,
40675,
7856,
575,
9606,
27749,
235265,
139,
135779,
489,
19573,
6565,
473,
591,
109806,
235275,
64593,
10565,
576,
3118,
5330,
5999,
578,
1170,
25416,
223285,
567,
229977,
578,
116631,
1411,
235265,
1448,
131081,
674,
573,
4232,
576,
163264,
1249,
614,
23913,
731,
4559,
575,
61484,
3057,
1972,
599,
235284,
591,
17051,
235305,
235284,
235275,
578,
92757,
3027,
1411,
235265,
16544,
9202,
578,
4442,
8914,
12749,
4956,
99795,
3515,
112170,
103999,
12603,
591,
135779,
567,
236205,
235275,
80232,
6606,
591,
235304,
235276,
235276,
235955,
235327,
235283,
6482,
846,
5193,
26609,
5902,
1049,
28234,
696,
31472,
578,
235248,
235310,
235269,
235248,
235284,
235310,
235269,
235248,
235310,
235321,
578,
235248,
235324,
235284,
235955,
28068,
1452,
68277,
235265,
637,
567,
103999,
12603,
6629,
22157,
235305,
235284,
5902,
731,
235248,
235274,
235310,
235276,
13520,
948,
8951,
18279,
696,
235248,
235310,
235321,
235955,
28068,
591,
235318,
235265,
235318,
101690,
235308,
235955,
512,
235283,
1522,
5135,
235265,
235248,
235274,
235308,
101690,
235315,
235955,
512,
235283,
1522,
235289,
503,
44450,
235276,
235265,
235276,
235310,
235310,
235275,
578,
13484,
696,
674,
2403,
696,
235248,
235324,
235284,
235955,
28068,
235265,
878,
2017,
235269,
112170,
103999,
12603,
6629,
637,
235290,
4935,
473,
5902,
731,
235248,
235284,
235308,
235358,
3303,
696,
235248,
235284,
235310,
235955,
28068,
591,
235304,
235315,
101690,
235284,
235274,
235955,
512,
235283,
1522,
5135,
235265,
235248,
235310,
235315,
101690,
235284,
235318,
235955,
512,
235283,
1522,
235289,
503,
109165,
235276,
235265,
235276,
235276,
235274,
235275,
948,
21352,
696,
736,
2403,
3274,
235248,
235324,
235284,
235955,
28068,
591,
235263,
109165,
235276,
235265,
235276,
235276,
235274,
846,
714,
12310,
575,
116631,
22525,
33334,
149321,
577,
671,
235248,
235321,
235321,
235358,
4740,
575,
69564,
12864,
67251,
1625,
591,
235310,
235304,
101690,
235274,
235276,
224971,
235274,
235276,
235278,
235315,
9388,
235257,
5135,
235265,
235248,
235321,
235274,
101690,
235274,
235324,
224971,
235274,
235276,
235278,
235315,
9388,
235257,
235289,
503,
109165,
235276,
235265,
235276,
235276,
235274,
235275,
578,
476,
235248,
235315,
235358,
4740,
575,
116631,
1625,
696,
235248,
235324,
235284,
235955,
28068,
591,
235284,
235284,
235310,
101690,
235310,
235308,
224971,
235274,
235276,
235278,
235315,
9388,
235257,
5135,
235265,
235248,
235284,
235310,
235310,
101690,
235308,
235284,
224971,
235274,
235276,
235278,
235315,
9388,
235257,
235289,
503,
44450,
235276,
235265,
235276,
235276,
235308,
846,
137975,
30306,
643,
19651,
578,
2232,
53486,
15524,
7435,
21637,
1049,
780,
12879,
30776,
731,
112170,
103999,
12603,
235265,
85384,
235269,
15408,
10216,
575,
573,
31472,
5902,
576,
637,
235290,
4935,
473,
578,
61484,
30306,
643,
19651,
1049,
8674,
235265,
637,
235290,
4935,
473,
578,
61484,
30306,
643,
19651,
5902,
1049,
45552,
575,
1359,
7631,
577,
3576,
591,
235308,
235274,
101690,
235284,
235310,
578,
235248,
235284,
235321,
101690,
235274,
235276,
235955,
512,
235283,
1522,
235289,
503,
44450,
235276,
235265,
235276,
235284,
235308,
578,
235248,
235304,
235276,
101690,
235308,
235955,
512,
235283,
1522,
5135,
235265,
235248,
235274,
235318,
101690,
235308,
235955,
512,
235283,
1522,
235289,
503,
44450,
235276,
235265,
235276,
235276,
235284,
235269,
11235,
846,
163264,
12062,
22157,
235305,
235284,
24030,
5902,
578,
45596,
637,
235290,
4935,
473,
235265,
12214,
6438,
708,
4880,
577,
24260,
4270,
1450,
33334,
2613,
614,
7275,
604,
30567,
576,
223285,
565,
27198,
5685,
2290,
163264,
235290,
34606,
578,
4270,
44279,
576,
61484,
3057,
1972,
10565,
1249,
4581,
223285,
802,
35237,
2290,
163264,
5158,
235292,
128469,
235276,
235274,
235304,
235315,
235284,
235318,
235274,
235284,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
1639,
590,
221590,
55883,
235371,
179440,
21139,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
8745,
45146,
591,
235305,
133723,
1334,
16408,
5423,
40520,
235269,
209247,
187059,
235269,
33593,
216143,
235275,
2764,
575,
11137,
675,
61978,
9416,
162885,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. To study the efficacy and safety of phosphatidylserine (PS) containing Omega3 long-chain polyunsaturated fatty acids attached to its backbone (PS-Omega3) in reducing attention-deficit/ hyperactivity disorder (ADHD) symptoms in children. A 15-week, double-blind, placebo-controlled phase followed by an open-label extension of additional 15 weeks. Two hundred ADHD children were randomized to receive either PS-Omega3 or placebo, out of them, 150 children continued into the extension. Efficacy was assessed using Conners' parent and teacher rating scales (CRS-P,T), Strengths and Difficulties Questionnaire (SDQ), and Child Health Questionnaire (CHQ). Safety evaluation included adverse events monitoring. The key finding of the double-blind phase was the significant reduction in the Global:Restless/impulsive subscale of CRS-P and the significant improvement in Parent impact-emotional (PE) subscale of the CHQ, both in the PS-Omega3 group. Exploratory subgroup analysis of children with a more pronounced hyperactive/impulsive behavior, as well as mood and behavior-dysregulation, revealed a significant reduction in the ADHD-Index and hyperactive components. Data from the open-label extension indicated sustained efficacy for children who continued to receive PS-Omega3. Children that switched to PS-Omega3 treatment from placebo showed a significant reduction in subscales scores of both CRS-P and the CRS-T, as compare to baseline scores. The treatment was well tolerated. The results of this 30-week study suggest that PS-Omega3 may reduce ADHD symptoms in children. Preliminary analysis suggests that this treatment may be especially effective in a subgroup of hyperactive-impulsive, emotionally and behaviorally-dysregulated ADHD children. Output: | {'conditions': 'Attention Deficit/Hyperactivity Disorder (ADHD)', 'interventions': 'Dietary Supplement: Phosphatidylserine-Omega3|Other: Colored cellulose tainted with fishy odor'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. To study the efficacy and safety of phosphatidylserine (PS) containing Omega3 long-chain polyunsaturated fatty acids attached to its backbone (PS-Omega3) in reducing attention-deficit/ hyperactivity disorder (ADHD) symptoms in children. A 15-week, double-blind, placebo-controlled phase followed by an open-label extension of additional 15 weeks. Two hundred ADHD children were randomized to receive either PS-Omega3 or placebo, out of them, 150 children continued into the extension. Efficacy was assessed using Conners' parent and teacher rating scales (CRS-P,T), Strengths and Difficulties Questionnaire (SDQ), and Child Health Questionnaire (CHQ). Safety evaluation included adverse events monitoring. The key finding of the double-blind phase was the significant reduction in the Global:Restless/impulsive subscale of CRS-P and the significant improvement in Parent impact-emotional (PE) subscale of the CHQ, both in the PS-Omega3 group. Exploratory subgroup analysis of children with a more pronounced hyperactive/impulsive behavior, as well as mood and behavior-dysregulation, revealed a significant reduction in the ADHD-Index and hyperactive components. Data from the open-label extension indicated sustained efficacy for children who continued to receive PS-Omega3. Children that switched to PS-Omega3 treatment from placebo showed a significant reduction in subscales scores of both CRS-P and the CRS-T, as compare to baseline scores. The treatment was well tolerated. The results of this 30-week study suggest that PS-Omega3 may reduce ADHD symptoms in children. Preliminary analysis suggests that this treatment may be especially effective in a subgroup of hyperactive-impulsive, emotionally and behaviorally-dysregulated ADHD children. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Attention Deficit/Hyperactivity Disorder (ADHD)', 'interventions': 'Dietary Supplement: Phosphatidylserine-Omega3|Other: Colored cellulose tainted with fishy odor'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
651,
4232,
576,
76903,
185521,
1098,
622,
10751,
49377,
235304,
39789,
235290,
189936,
611,
6137,
235290,
495,
109661,
13099,
12019,
24283,
12447,
575,
3069,
235292,
476,
4199,
235290,
58122,
70061,
235290,
41789,
7856,
235269,
7599,
731,
671,
2174,
235290,
2097,
10957,
235265,
139,
1469,
3320,
573,
43391,
578,
6514,
576,
76903,
185521,
1098,
622,
591,
3817,
235275,
10751,
49377,
235304,
1497,
235290,
11607,
7355,
214364,
39789,
22589,
12412,
577,
1277,
76153,
591,
3817,
235290,
14731,
235304,
235275,
575,
18442,
6137,
235290,
495,
109661,
235283,
13099,
12019,
24283,
591,
151189,
235275,
12447,
575,
3069,
235265,
586,
235248,
235274,
235308,
235290,
13118,
235269,
4199,
235290,
58122,
235269,
70061,
235290,
41789,
8342,
7599,
731,
671,
2174,
235290,
2097,
10957,
576,
5942,
235248,
235274,
235308,
5976,
235265,
7020,
7541,
68239,
3069,
1049,
74016,
577,
6427,
3906,
11552,
235290,
14731,
235304,
689,
70061,
235269,
921,
576,
1174,
235269,
235248,
235274,
235308,
235276,
3069,
7822,
1280,
573,
10957,
235265,
179371,
729,
28234,
2177,
1419,
4013,
235303,
3910,
578,
9382,
12613,
25705,
591,
125667,
235290,
235295,
235269,
235279,
823,
160924,
578,
173830,
98520,
591,
6896,
235368,
823,
578,
8072,
5101,
98520,
591,
2026,
235368,
846,
14002,
13167,
5484,
23289,
5562,
14251,
235265,
714,
2621,
10488,
576,
573,
4199,
235290,
58122,
8342,
729,
573,
4937,
12025,
575,
573,
10799,
235292,
11022,
1959,
235283,
10308,
63877,
1334,
9144,
576,
125147,
235290,
235295,
578,
573,
4937,
13194,
575,
19516,
6418,
235290,
121123,
591,
3328,
235275,
1334,
9144,
576,
573,
4029,
235368,
235269,
2145,
575,
573,
11552,
235290,
14731,
235304,
2778,
235265,
109342,
4253,
74236,
4084,
576,
3069,
675,
476,
978,
32861,
13099,
5087,
235283,
10308,
63877,
8409,
235269,
685,
1578,
685,
18068,
578,
8409,
235290,
104079,
70633,
235269,
12570,
476,
4937,
12025,
575,
573,
68239,
235290,
3079,
578,
13099,
5087,
8832,
235265,
4145,
774,
573,
2174,
235290,
2097,
10957,
11969,
27476,
43391,
604,
3069,
1064,
7822,
577,
6427,
11552,
235290,
14731,
235304,
235265,
12773,
674,
36429,
577,
11552,
235290,
14731,
235304,
5158,
774,
70061,
8588,
476,
4937,
12025,
575,
5226,
108164,
16382,
576,
2145,
125147,
235290,
235295,
578,
573,
125147,
235290,
235279,
235269,
685,
12711,
577,
31472,
16382,
235265,
714,
5158,
729,
1578,
82277,
235265,
714,
3190,
576,
736,
235248,
235304,
235276,
235290,
13118,
3320,
9337,
674,
11552,
235290,
14731,
235304,
1249,
8339,
68239,
12447,
575,
3069,
235265,
58977,
4084,
15904,
674,
736,
5158,
1249,
614,
5199,
7017,
575,
476,
74236,
576,
13099,
5087,
235290,
10308,
63877,
235269,
55068,
578,
8409,
858,
235290,
104079,
63951,
68239,
3069,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
41261,
211263,
235283,
38954,
12019,
80825,
591,
151189,
32618,
777,
2018,
62992,
2130,
777,
187706,
50118,
235292,
127889,
620,
185521,
1098,
622,
235290,
14731,
235304,
235371,
6273,
235292,
109679,
77723,
150069,
675,
178414,
45824,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia. Individual malaria interventions provide only partial protection in most epidemiological situations. Thus, there is a need to investigate whether combining interventions provides added benefit in reducing mortality and morbidity from malaria. The potential benefits of combining IPT in children (IPTc) with home management of malaria (HMM) was investigated. During the 2008 malaria transmission season, 1,277 children under five years of age resident in villages within the rural Farafenni demographic surveillance system (DSS) in North Bank Region, The Gambia were randomized to receive monthly IPTc with a single dose of sulphadoxine/pyrimethamine (SP) plus three doses of amodiaquine (AQ) or SP and AQ placebos given by village health workers (VHWs) on three occasions during the months of September, October and November, in a double-blind trial. Children in all study villages who developed an acute febrile illness suggestive of malaria were treated by VHWs who had been taught how to manage malaria with artemether-lumefantrine (Coartem™). The primary aims of the project were to determine whether IPTc added significant benefit to HMM and whether VHWs could effectively combine the delivery of both interventions. The incidence of clinical attacks of malaria was very low in both study groups. The incidence rate of malaria in children who received IPTc was 0.44 clinical attacks per 1,000 child months at risk while that for control children was 1.32 per 1,000 child months at risk, a protective efficacy of 66% (95% CI -23% to 96%; p = 0.35). The mean (standard deviation) haemoglobin concentration at the end of the malaria transmission season was similar in the two treatment groups: 10.2 (1.6) g/dL in the IPTc group compared to 10.3 (1.5) g/dL in the placebo group. Coverage with IPTc was high, with 94% of children receiving all three treatments during the study period. Due to the very low incidence of malaria, no firm conclusion can be drawn on the added benefit of IPTc in preventing clinical episodes of malaria among children who had access to HMM in The Gambia. However, the study showed that VHWs can successfully combine provision of HMM with provision of IPTc. Output: | {'conditions': 'Malaria', 'interventions': 'Drug: SP plus amodiaquine|Drug: SP placebo plus amodiaquine placebo'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia. Individual malaria interventions provide only partial protection in most epidemiological situations. Thus, there is a need to investigate whether combining interventions provides added benefit in reducing mortality and morbidity from malaria. The potential benefits of combining IPT in children (IPTc) with home management of malaria (HMM) was investigated. During the 2008 malaria transmission season, 1,277 children under five years of age resident in villages within the rural Farafenni demographic surveillance system (DSS) in North Bank Region, The Gambia were randomized to receive monthly IPTc with a single dose of sulphadoxine/pyrimethamine (SP) plus three doses of amodiaquine (AQ) or SP and AQ placebos given by village health workers (VHWs) on three occasions during the months of September, October and November, in a double-blind trial. Children in all study villages who developed an acute febrile illness suggestive of malaria were treated by VHWs who had been taught how to manage malaria with artemether-lumefantrine (Coartem™). The primary aims of the project were to determine whether IPTc added significant benefit to HMM and whether VHWs could effectively combine the delivery of both interventions. The incidence of clinical attacks of malaria was very low in both study groups. The incidence rate of malaria in children who received IPTc was 0.44 clinical attacks per 1,000 child months at risk while that for control children was 1.32 per 1,000 child months at risk, a protective efficacy of 66% (95% CI -23% to 96%; p = 0.35). The mean (standard deviation) haemoglobin concentration at the end of the malaria transmission season was similar in the two treatment groups: 10.2 (1.6) g/dL in the IPTc group compared to 10.3 (1.5) g/dL in the placebo group. Coverage with IPTc was high, with 94% of children receiving all three treatments during the study period. Due to the very low incidence of malaria, no firm conclusion can be drawn on the added benefit of IPTc in preventing clinical episodes of malaria among children who had access to HMM in The Gambia. However, the study showed that VHWs can successfully combine provision of HMM with provision of IPTc. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Malaria', 'interventions': 'Drug: SP plus amodiaquine|Drug: SP placebo plus amodiaquine placebo'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
235280,
7856,
576,
80597,
65393,
5158,
578,
2078,
235290,
6576,
4815,
576,
65707,
575,
476,
13136,
2713,
576,
714,
133706,
235265,
139,
36872,
65707,
40126,
3658,
1297,
13427,
6919,
575,
1546,
159525,
15212,
235265,
8707,
235269,
1104,
603,
476,
1476,
577,
24260,
4270,
38894,
40126,
6572,
4192,
9065,
575,
18442,
27470,
578,
119852,
774,
65707,
235265,
714,
5736,
7839,
576,
38894,
85307,
575,
3069,
591,
2520,
80520,
235275,
675,
2078,
4815,
576,
65707,
591,
204033,
235275,
729,
26344,
235265,
9931,
573,
235248,
235284,
235276,
235276,
235321,
65707,
16102,
3891,
235269,
235248,
235274,
235269,
235284,
235324,
235324,
3069,
1362,
4105,
1658,
576,
3911,
19099,
575,
25435,
2819,
573,
13136,
170648,
6660,
940,
51157,
35469,
1812,
591,
149780,
235275,
575,
4612,
6226,
15306,
235269,
714,
133706,
1049,
74016,
577,
6427,
16229,
85307,
235260,
675,
476,
3821,
17050,
576,
7809,
3158,
108203,
622,
235283,
2158,
505,
36657,
20724,
591,
3085,
235275,
2755,
2149,
33579,
576,
29577,
2197,
144264,
591,
69172,
235275,
689,
7288,
578,
116935,
2040,
14084,
2764,
731,
9552,
2962,
8218,
591,
235330,
34827,
235256,
235275,
611,
2149,
23223,
2290,
573,
4063,
576,
5225,
235269,
5424,
578,
5516,
235269,
575,
476,
4199,
235290,
58122,
7856,
235265,
12773,
575,
832,
3320,
25435,
1064,
6990,
671,
21825,
209748,
494,
17999,
89528,
576,
65707,
1049,
11017,
731,
744,
34827,
235256,
1064,
1093,
1125,
14537,
1368,
577,
12607,
65707,
675,
14680,
504,
790,
235290,
853,
504,
10144,
17197,
591,
3078,
210944,
236649,
846,
714,
7920,
22346,
576,
573,
3542,
1049,
577,
8363,
4270,
85307,
235260,
4192,
4937,
9065,
577,
200031,
578,
4270,
744,
34827,
235256,
1538,
16347,
21364,
573,
8335,
576,
2145,
40126,
235265,
714,
34760,
576,
13324,
15502,
576,
65707,
729,
1508,
3178,
575,
2145,
3320,
5452,
235265,
714,
34760,
3974,
576,
65707,
575,
3069,
1064,
4956,
85307,
235260,
729,
235248,
235276,
235265,
235310,
235310,
13324,
15502,
842,
235248,
235274,
235269,
235276,
235276,
235276,
2047,
4063,
696,
5685,
2183,
674,
604,
2582,
3069,
729,
235248,
235274,
235265,
235304,
235284,
842,
235248,
235274,
235269,
235276,
235276,
235276,
2047,
4063,
696,
5685,
235269,
476,
21526,
43391,
576,
235248,
235318,
235318,
235358,
591,
235315,
235308,
235358,
22788,
728,
235284,
235304,
235358,
577,
235248,
235315,
235318,
11542,
503,
589,
235248,
235276,
235265,
235304,
235308,
846,
714,
2714,
591,
21795,
25760,
235275,
78966,
110865,
11880,
696,
573,
1580,
576,
573,
65707,
16102,
3891,
729,
3968,
575,
573,
1378,
5158,
5452,
235292,
235248,
235274,
235276,
235265,
235284,
591,
235274,
235265,
235318,
235275,
583,
235283,
92854,
575,
573,
85307,
235260,
2778,
7631,
577,
235248,
235274,
235276,
235265,
235304,
591,
235274,
235265,
235308,
235275,
583,
235283,
92854,
575,
573,
70061,
2778,
235265,
53453,
675,
85307,
235260,
729,
1536,
235269,
675,
235248,
235315,
235310,
235358,
576,
3069,
14051,
832,
2149,
21782,
2290,
573,
3320,
4037,
235265,
21561,
577,
573,
1508,
3178,
34760,
576,
65707,
235269,
793,
7650,
13856,
798,
614,
11288,
611,
573,
4192,
9065,
576,
85307,
235260,
575,
32842,
13324,
24958,
576,
65707,
3932,
3069,
1064,
1093,
3684,
577,
200031,
575,
714,
133706,
235265,
4560,
235269,
573,
3320,
8588,
674,
744,
34827,
235256,
798,
13292,
21364,
9018,
576,
200031,
675,
9018,
576,
85307,
235260,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
12293,
4357,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
7288,
2755,
29577,
2197,
144264,
235371,
55031,
235292,
7288,
70061,
2755,
29577,
2197,
144264,
70061,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Long-term complications of critical illness include intensive care unit (ICU)-acquired weakness and neuropsychiatric disease. Immobilisation secondary to sedation might potentiate these problems. We assessed the efficacy of combining daily interruption of sedation with physical and occupational therapy on functional outcomes in patients receiving mechanical ventilation in intensive care. Sedated adults (>/=18 years of age) in the ICU who had been on mechanical ventilation for less than 72 h, were expected to continue for at least 24 h, and who met criteria for baseline functional independence were eligible for enrolment in this randomised controlled trial at two university hospitals. We randomly assigned 104 patients by computer-generated, permuted block randomisation to early exercise and mobilisation (physical and occupational therapy) during periods of daily interruption of sedation (intervention; n=49) or to daily interruption of sedation with therapy as ordered by the primary care team (control; n=55). The primary endpoint-the number of patients returning to independent functional status at hospital discharge-was defined as the ability to perform six activities of daily living and the ability to walk independently. Therapists who undertook patient assessments were blinded to treatment assignment. Secondary endpoints included duration of delirium and ventilator-free days during the first 28 days of hospital stay. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00322010. All 104 patients were included in the analysis. Return to independent functional status at hospital discharge occurred in 29 (59%) patients in the intervention group compared with 19 (35%) patients in the control group (p=0.02; odds ratio 2.7 [95% CI 1.2-6.1]). Patients in the intervention group had shorter duration of delirium (median 2.0 days, IQR 0.0-6.0 vs 4.0 days, 2.0-8.0; p=0.02), and more ventilator-free days (23.5 days, 7.4-25.6 vs 21.1 days, 0.0-23.8; p=0.05) during the 28-day follow-up period than did controls. There was one serious adverse event in 498 therapy sessions (desaturation less than 80%). Discontinuation of therapy as a result of patient instability occurred in 19 (4%) of all sessions, most commonly for perceived patient-ventilator asynchrony. A strategy for whole-body rehabilitation-consisting of interruption of sedation and physical and occupational therapy in the earliest days of critical illness-was safe and well tolerated, and resulted in better functional outcomes at hospital discharge, a shorter duration of delirium, and more ventilator-free days compared with standard care. None. Output: | {'conditions': 'Streptococcus Pneumoniae Vaccines', 'interventions': 'Drug: Quetiapine'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Long-term complications of critical illness include intensive care unit (ICU)-acquired weakness and neuropsychiatric disease. Immobilisation secondary to sedation might potentiate these problems. We assessed the efficacy of combining daily interruption of sedation with physical and occupational therapy on functional outcomes in patients receiving mechanical ventilation in intensive care. Sedated adults (>/=18 years of age) in the ICU who had been on mechanical ventilation for less than 72 h, were expected to continue for at least 24 h, and who met criteria for baseline functional independence were eligible for enrolment in this randomised controlled trial at two university hospitals. We randomly assigned 104 patients by computer-generated, permuted block randomisation to early exercise and mobilisation (physical and occupational therapy) during periods of daily interruption of sedation (intervention; n=49) or to daily interruption of sedation with therapy as ordered by the primary care team (control; n=55). The primary endpoint-the number of patients returning to independent functional status at hospital discharge-was defined as the ability to perform six activities of daily living and the ability to walk independently. Therapists who undertook patient assessments were blinded to treatment assignment. Secondary endpoints included duration of delirium and ventilator-free days during the first 28 days of hospital stay. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00322010. All 104 patients were included in the analysis. Return to independent functional status at hospital discharge occurred in 29 (59%) patients in the intervention group compared with 19 (35%) patients in the control group (p=0.02; odds ratio 2.7 [95% CI 1.2-6.1]). Patients in the intervention group had shorter duration of delirium (median 2.0 days, IQR 0.0-6.0 vs 4.0 days, 2.0-8.0; p=0.02), and more ventilator-free days (23.5 days, 7.4-25.6 vs 21.1 days, 0.0-23.8; p=0.05) during the 28-day follow-up period than did controls. There was one serious adverse event in 498 therapy sessions (desaturation less than 80%). Discontinuation of therapy as a result of patient instability occurred in 19 (4%) of all sessions, most commonly for perceived patient-ventilator asynchrony. A strategy for whole-body rehabilitation-consisting of interruption of sedation and physical and occupational therapy in the earliest days of critical illness-was safe and well tolerated, and resulted in better functional outcomes at hospital discharge, a shorter duration of delirium, and more ventilator-free days compared with standard care. None. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Streptococcus Pneumoniae Vaccines', 'interventions': 'Drug: Quetiapine'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
18428,
6915,
578,
49020,
13414,
575,
95617,
122853,
235269,
57278,
3070,
6022,
235292,
476,
192036,
15081,
7856,
235265,
139,
6604,
235290,
7617,
35237,
576,
9523,
17999,
3707,
32713,
2212,
4982,
591,
138268,
7817,
164857,
23432,
578,
20109,
162617,
1337,
7197,
235265,
7335,
31169,
5076,
13752,
577,
187108,
2613,
41435,
607,
1450,
4552,
235265,
1448,
28234,
573,
43391,
576,
38894,
7074,
79067,
576,
187108,
675,
6915,
578,
49020,
13414,
611,
15859,
18701,
575,
6022,
14051,
16801,
36288,
575,
32713,
2212,
235265,
23996,
840,
14257,
591,
49385,
235293,
235274,
235321,
1658,
576,
3911,
235275,
575,
573,
83332,
1064,
1093,
1125,
611,
16801,
36288,
604,
2644,
1178,
235248,
235324,
235284,
531,
235269,
1049,
5043,
577,
5374,
604,
696,
3476,
235248,
235284,
235310,
531,
235269,
578,
1064,
2211,
12830,
604,
31472,
15859,
22413,
1049,
22075,
604,
137588,
575,
736,
192036,
15081,
7856,
696,
1378,
13435,
24431,
235265,
1448,
36011,
15696,
235248,
235274,
235276,
235310,
6022,
731,
6875,
235290,
7618,
235269,
842,
66016,
3963,
6253,
5076,
577,
4061,
9987,
578,
162054,
591,
32873,
578,
49020,
13414,
235275,
2290,
16049,
576,
7074,
79067,
576,
187108,
591,
87893,
235289,
552,
235293,
235310,
235315,
235275,
689,
577,
7074,
79067,
576,
187108,
675,
13414,
685,
11538,
731,
573,
7920,
2212,
2970,
591,
7044,
235289,
552,
235293,
235308,
235308,
846,
714,
7920,
37875,
235290,
1175,
1758,
576,
6022,
18147,
577,
9560,
15859,
4938,
696,
7454,
19738,
235290,
6570,
6908,
685,
573,
7374,
577,
3114,
4442,
5728,
576,
7074,
5027,
578,
573,
7374,
577,
5376,
30601,
235265,
119217,
3802,
1064,
85682,
7679,
37921,
1049,
109891,
577,
5158,
22312,
235265,
36269,
79833,
5484,
14827,
576,
173296,
578,
146062,
235290,
4816,
2705,
2290,
573,
1370,
235248,
235284,
235321,
2705,
576,
7454,
4692,
235265,
8272,
729,
731,
15527,
577,
3516,
235265,
1417,
7856,
603,
14198,
675,
27998,
132440,
235265,
9789,
235269,
1758,
128469,
235276,
235276,
235304,
235284,
235284,
235276,
235274,
235276,
235265,
2262,
235248,
235274,
235276,
235310,
6022,
1049,
5484,
575,
573,
4084,
235265,
13366,
577,
9560,
15859,
4938,
696,
7454,
19738,
12414,
575,
235248,
235284,
235315,
591,
235308,
235315,
8722,
6022,
575,
573,
21683,
2778,
7631,
675,
235248,
235274,
235315,
591,
235304,
235308,
8722,
6022,
575,
573,
2582,
2778,
591,
235263,
235293,
235276,
235265,
235276,
235284,
235289,
30028,
9537,
235248,
235284,
235265,
235324,
892,
235315,
235308,
235358,
22788,
235248,
235274,
235265,
235284,
235290,
235318,
235265,
235274,
24602,
38586,
575,
573,
21683,
2778,
1093,
25270,
14827,
576,
173296,
591,
62102,
235248,
235284,
235265,
235276,
2705,
235269,
590,
31064,
235248,
235276,
235265,
235276,
235290,
235318,
235265,
235276,
5135,
235248,
235310,
235265,
235276,
2705,
235269,
235248,
235284,
235265,
235276,
235290,
235321,
235265,
235276,
235289,
503,
235293,
235276,
235265,
235276,
235284,
823,
578,
978,
146062,
235290,
4816,
2705,
591,
235284,
235304,
235265,
235308,
2705,
235269,
235248,
235324,
235265,
235310,
235290,
235284,
235308,
235265,
235318,
5135,
235248,
235284,
235274,
235265,
235274,
2705,
235269,
235248,
235276,
235265,
235276,
235290,
235284,
235304,
235265,
235321,
235289,
503,
235293,
235276,
235265,
235276,
235308,
235275,
2290,
573,
235248,
235284,
235321,
235290,
1311,
1611,
235290,
1021,
4037,
1178,
1498,
13753,
235265,
2456,
729,
974,
6449,
23289,
3071,
575,
235248,
235310,
235315,
235321,
13414,
16567,
591,
1609,
152044,
2644,
1178,
235248,
235321,
235276,
39943,
2900,
190461,
576,
13414,
685,
476,
2196,
576,
7679,
53055,
12414,
575,
235248,
235274,
235315,
591,
235310,
8722,
576,
832,
16567,
235269,
1546,
17203,
604,
29240,
7679,
235290,
70413,
1291,
685,
13075,
235267,
235265,
586,
9803,
604,
3733,
235290,
2168,
38433,
235290,
759,
135485,
576,
79067,
576,
187108,
578,
6915,
578,
49020,
13414,
575,
573,
30653,
2705,
576,
9523,
17999,
235290,
6570,
5985,
578,
1578,
82277,
235269,
578,
19499,
575,
2525,
15859,
18701,
696,
7454,
19738,
235269,
476,
25270,
14827,
576,
173296,
235269,
578,
978,
146062,
235290,
4816,
2705,
7631,
675,
5039,
2212,
235265,
4090,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
184913,
52878,
222754,
235249,
159171,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
6197,
82838,
622,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial. Levodopa use in fluctuating Parkinson's disease (PD) is complicated by an inconsistent and prolonged onset to clinical improvement. An orally dissolved carbidopa/levodopa (OD C/L) preparation (Parcopa UCB Pharma) is available in the United States. This offers potential advantages to shorten the duration from ingestion to clinical improvement. Surprisingly, this has never been clinically assessed. We tested 20 patients with fluctuating PD and a Unified Parkinson's Disease Rating Scale (UPDRS) "off" motor score of ≥ 25 in a 2-day, single-dose, double-blind, double-dummy, crossover study. Patients arrived in the morning in the practically defined "off" state and were randomly assigned to receive identical doses of either oral C/L and OD placebo or OD C/L and oral C/L placebo on 1st day and the reverse combination on a 2nd day. After training, patients underwent bilateral hand tapping at baseline and every 5 minutes for 60 minutes after dose ingestion. Stride length (SL) was recorded at 5-minute intervals with an ambulatory gait monitor. Patients identified their subjective latency to "on" and noted drug preferences and adverse events. They also underwent a UPDRS motor examination at baseline and 60 minutes after dose. Twenty subjects [15 male, age 68.7 (9.7), PD duration 13.4 (6.8)] completed. There were no significant group differences in tapping speed, subjective time to "on," latency of increased SL, or overall preference. However, all trends did favor OD C/L. Adverse events were similar. This small pilot study did not show significant group differences favoring OD C/L; however, larger studies may be justified, and individual patients may benefit. Output: | {'conditions': 'Haemophilus Influenza Infections', 'interventions': 'Drug: aripiprazole|Biological: StrataGraft Skin Tissue'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial. Levodopa use in fluctuating Parkinson's disease (PD) is complicated by an inconsistent and prolonged onset to clinical improvement. An orally dissolved carbidopa/levodopa (OD C/L) preparation (Parcopa UCB Pharma) is available in the United States. This offers potential advantages to shorten the duration from ingestion to clinical improvement. Surprisingly, this has never been clinically assessed. We tested 20 patients with fluctuating PD and a Unified Parkinson's Disease Rating Scale (UPDRS) "off" motor score of ≥ 25 in a 2-day, single-dose, double-blind, double-dummy, crossover study. Patients arrived in the morning in the practically defined "off" state and were randomly assigned to receive identical doses of either oral C/L and OD placebo or OD C/L and oral C/L placebo on 1st day and the reverse combination on a 2nd day. After training, patients underwent bilateral hand tapping at baseline and every 5 minutes for 60 minutes after dose ingestion. Stride length (SL) was recorded at 5-minute intervals with an ambulatory gait monitor. Patients identified their subjective latency to "on" and noted drug preferences and adverse events. They also underwent a UPDRS motor examination at baseline and 60 minutes after dose. Twenty subjects [15 male, age 68.7 (9.7), PD duration 13.4 (6.8)] completed. There were no significant group differences in tapping speed, subjective time to "on," latency of increased SL, or overall preference. However, all trends did favor OD C/L. Adverse events were similar. This small pilot study did not show significant group differences favoring OD C/L; however, larger studies may be justified, and individual patients may benefit. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Haemophilus Influenza Infections', 'interventions': 'Drug: aripiprazole|Biological: StrataGraft Skin Tissue'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
33714,
576,
106528,
128247,
33636,
2476,
569,
235283,
4123,
12581,
569,
591,
1885,
95079,
235275,
577,
21899,
19131,
33636,
2476,
569,
235283,
4123,
12581,
569,
235292,
586,
3821,
235290,
43844,
235269,
4199,
235290,
58122,
235269,
4199,
235290,
41735,
235269,
70061,
235290,
41789,
235269,
58115,
7856,
235265,
139,
87959,
12581,
569,
1281,
575,
140998,
65001,
235303,
235256,
7197,
591,
4023,
235275,
603,
20433,
731,
671,
47355,
578,
42247,
42673,
577,
13324,
13194,
235265,
1364,
106528,
35532,
33636,
2476,
569,
235283,
4123,
12581,
569,
591,
2120,
585,
235283,
235301,
235275,
12988,
591,
1885,
95079,
169701,
20755,
235275,
603,
2506,
575,
573,
3520,
3858,
235265,
1417,
6952,
5736,
17927,
577,
98880,
573,
14827,
774,
109002,
577,
13324,
13194,
235265,
163882,
235269,
736,
919,
2447,
1125,
84586,
28234,
235265,
1448,
12272,
235248,
235284,
235276,
6022,
675,
140998,
28528,
578,
476,
88996,
65001,
235303,
235256,
26995,
25876,
26830,
591,
58144,
8862,
235275,
664,
2672,
235281,
5980,
7716,
576,
56424,
235248,
235284,
235308,
575,
476,
235248,
235284,
235290,
1311,
235269,
3821,
235290,
43844,
235269,
4199,
235290,
58122,
235269,
4199,
235290,
41735,
235269,
58115,
3320,
235265,
38586,
11987,
575,
573,
5764,
575,
573,
25426,
6908,
664,
2672,
235281,
2329,
578,
1049,
36011,
15696,
577,
6427,
20745,
33579,
576,
3906,
19131,
585,
235283,
235301,
578,
45367,
70061,
689,
45367,
585,
235283,
235301,
578,
19131,
585,
235283,
235301,
70061,
611,
235248,
235274,
490,
1744,
578,
573,
14884,
11137,
611,
476,
235248,
235284,
491,
1744,
235265,
4660,
4770,
235269,
6022,
66626,
49627,
1634,
69967,
696,
31472,
578,
1535,
235248,
235308,
4363,
604,
235248,
235318,
235276,
4363,
1452,
17050,
109002,
235265,
997,
1326,
4191,
591,
9011,
235275,
729,
11659,
696,
235248,
235308,
235290,
21306,
24580,
675,
671,
215328,
88353,
8200,
235265,
38586,
10638,
1024,
45927,
65325,
577,
664,
477,
235281,
578,
9611,
10471,
22733,
578,
23289,
5562,
235265,
2365,
1170,
66626,
476,
80354,
8862,
5980,
14433,
696,
31472,
578,
235248,
235318,
235276,
4363,
1452,
17050,
235265,
38611,
12749,
892,
235274,
235308,
9202,
235269,
3911,
235248,
235318,
235321,
235265,
235324,
591,
235315,
235265,
235324,
823,
28528,
14827,
235248,
235274,
235304,
235265,
235310,
591,
235318,
235265,
235321,
6278,
8735,
235265,
2456,
1049,
793,
4937,
2778,
10216,
575,
69967,
4969,
235269,
45927,
1069,
577,
664,
477,
1985,
65325,
576,
6629,
16872,
235269,
689,
8691,
25768,
235265,
4560,
235269,
832,
17699,
1498,
4287,
45367,
585,
235283,
235301,
235265,
127057,
5562,
1049,
3968,
235265,
1417,
2301,
18576,
3320,
1498,
780,
1500,
4937,
2778,
10216,
151993,
45367,
585,
235283,
235301,
235289,
4187,
235269,
8107,
6438,
1249,
614,
35088,
235269,
578,
3811,
6022,
1249,
9065,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
230898,
108314,
173300,
137206,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
476,
5390,
1314,
10903,
1659,
235371,
84545,
235292,
4618,
784,
235319,
4468,
20120,
66692,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Community-associated methicillin-resistant Staphylococcus aureus is now the leading cause of uncomplicated skin abscesses in the United States, and the role of antibiotics is controversial. We evaluate whether trimethoprim-sulfamethoxazole reduces the rate of treatment failures during the 7 days after incision and drainage and whether it reduces new lesion formation within 30 days. In this multicenter, double-blind, randomized, placebo-controlled trial, we randomized adults to oral trimethoprim-sulfamethoxazole or placebo after uncomplicated abscess incision and drainage. Using emergency department rechecks at 2 and 7 days and telephone follow-up, we assessed treatment failure within 7 days, and using clinical follow-up, telephone follow-up, and medical record review, we recorded the development of new lesions within 30 days. We randomized 212 patients, and 190 (90%) were available for 7-day follow-up. We observed a statistically similar incidence of treatment failure in patients receiving trimethoprim-sulfamethoxazole (15/88; 17%) versus placebo (27/102; 26%), difference 9%, 95% confidence interval -2% to 21%; P=.12. On 30-day follow-up (successful in 69% of patients), we observed fewer new lesions in the antibiotic (4/46; 9%) versus placebo (14/50; 28%) groups, difference 19%, 95% confidence interval 4% to 34%, P=.02. After the incision and drainage of uncomplicated abscesses in adults, treatment with trimethoprim-sulfamethoxazole does not reduce treatment failure but may decrease the formation of subsequent lesions. Output: | {'conditions': 'Thalassemia Major', 'interventions': 'Other: enteral nutritional formula|Drug: Formoterol Turbuhaler'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Community-associated methicillin-resistant Staphylococcus aureus is now the leading cause of uncomplicated skin abscesses in the United States, and the role of antibiotics is controversial. We evaluate whether trimethoprim-sulfamethoxazole reduces the rate of treatment failures during the 7 days after incision and drainage and whether it reduces new lesion formation within 30 days. In this multicenter, double-blind, randomized, placebo-controlled trial, we randomized adults to oral trimethoprim-sulfamethoxazole or placebo after uncomplicated abscess incision and drainage. Using emergency department rechecks at 2 and 7 days and telephone follow-up, we assessed treatment failure within 7 days, and using clinical follow-up, telephone follow-up, and medical record review, we recorded the development of new lesions within 30 days. We randomized 212 patients, and 190 (90%) were available for 7-day follow-up. We observed a statistically similar incidence of treatment failure in patients receiving trimethoprim-sulfamethoxazole (15/88; 17%) versus placebo (27/102; 26%), difference 9%, 95% confidence interval -2% to 21%; P=.12. On 30-day follow-up (successful in 69% of patients), we observed fewer new lesions in the antibiotic (4/46; 9%) versus placebo (14/50; 28%) groups, difference 19%, 95% confidence interval 4% to 34%, P=.02. After the incision and drainage of uncomplicated abscesses in adults, treatment with trimethoprim-sulfamethoxazole does not reduce treatment failure but may decrease the formation of subsequent lesions. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Thalassemia Major', 'interventions': 'Other: enteral nutritional formula|Drug: Formoterol Turbuhaler'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
13020,
2012,
15081,
7856,
576,
1647,
36657,
715,
7918,
235290,
124142,
734,
489,
1863,
63911,
604,
214876,
5239,
109725,
484,
575,
6022,
696,
5685,
604,
4159,
235290,
49002,
682,
20829,
55013,
235290,
41381,
183827,
103714,
15618,
235265,
139,
25566,
235290,
49002,
682,
20829,
55013,
235290,
41381,
183827,
103714,
603,
1490,
573,
8133,
4557,
576,
214876,
5239,
109725,
484,
575,
573,
3520,
3858,
235269,
578,
573,
4731,
576,
58108,
603,
38357,
235265,
1448,
18739,
4270,
1647,
36657,
715,
7918,
235290,
124142,
734,
489,
1863,
63911,
25361,
573,
3974,
576,
5158,
36306,
2290,
573,
235248,
235324,
2705,
1452,
92170,
578,
30130,
578,
4270,
665,
25361,
888,
60229,
10565,
2819,
235248,
235304,
235276,
2705,
235265,
878,
736,
104221,
1068,
235269,
4199,
235290,
58122,
235269,
74016,
235269,
70061,
235290,
41789,
7856,
235269,
783,
74016,
14257,
577,
19131,
1647,
36657,
715,
7918,
235290,
124142,
734,
489,
1863,
63911,
689,
70061,
1452,
214876,
109725,
92170,
578,
30130,
235265,
12266,
13738,
9888,
582,
69423,
696,
235248,
235284,
578,
235248,
235324,
2705,
578,
19909,
1611,
235290,
1021,
235269,
783,
28234,
5158,
9633,
2819,
235248,
235324,
2705,
235269,
578,
2177,
13324,
1611,
235290,
1021,
235269,
19909,
1611,
235290,
1021,
235269,
578,
6910,
3661,
3221,
235269,
783,
11659,
573,
3505,
576,
888,
44053,
2819,
235248,
235304,
235276,
2705,
235265,
1448,
74016,
235248,
235284,
235274,
235284,
6022,
235269,
578,
235248,
235274,
235315,
235276,
591,
235315,
235276,
8722,
1049,
2506,
604,
235248,
235324,
235290,
1311,
1611,
235290,
1021,
235265,
1448,
8674,
476,
46527,
3968,
34760,
576,
5158,
9633,
575,
6022,
14051,
1647,
36657,
715,
7918,
235290,
124142,
734,
489,
1863,
63911,
591,
235274,
235308,
235283,
235321,
235321,
235289,
235248,
235274,
235324,
8722,
17529,
70061,
591,
235284,
235324,
235283,
235274,
235276,
235284,
235289,
235248,
235284,
235318,
36176,
5830,
235248,
235315,
13520,
235248,
235315,
235308,
235358,
12087,
15133,
728,
235284,
235358,
577,
235248,
235284,
235274,
11542,
596,
53927,
235274,
235284,
235265,
1993,
235248,
235304,
235276,
235290,
1311,
1611,
235290,
1021,
591,
39786,
575,
235248,
235318,
235315,
235358,
576,
6022,
823,
783,
8674,
23246,
888,
44053,
575,
573,
70786,
591,
235310,
235283,
235310,
235318,
235289,
235248,
235315,
8722,
17529,
70061,
591,
235274,
235310,
235283,
235308,
235276,
235289,
235248,
235284,
235321,
8722,
5452,
235269,
5830,
235248,
235274,
235315,
13520,
235248,
235315,
235308,
235358,
12087,
15133,
235248,
235310,
235358,
577,
235248,
235304,
235310,
13520,
596,
53927,
235276,
235284,
235265,
4660,
573,
92170,
578,
30130,
576,
214876,
109725,
484,
575,
14257,
235269,
5158,
675,
1647,
36657,
715,
7918,
235290,
124142,
734,
489,
1863,
63911,
1721,
780,
8339,
5158,
9633,
901,
1249,
16840,
573,
10565,
576,
17160,
44053,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
946,
44226,
6193,
740,
16665,
920,
777,
2018,
62992,
2130,
777,
6273,
235292,
3343,
492,
51307,
10513,
235371,
55031,
235292,
5779,
5629,
561,
6867,
1001,
2988,
475,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy. Fixed combinations of 0.2% brimonidine-0.5% timolol and 2% dorzolamide-0.5% timolol are used to lower intraocular pressure (IOP). The objective of this study was to evaluate the IOP-lowering efficacy and ocular tolerability of brimonidine-timolol compared with dorzolamide-timolol when used as monotherapy or as adjunctive therapy to a prostaglandin analog (PGA) in patients with glaucoma or ocular hypertension. Pooled data analysis of two randomized, investigator-masked, 3-month, parallel-group studies with identical protocols (ten sites). In all, 180 patients with open-angle glaucoma or ocular hypertension who were in need of lower IOP received topical brimonidine-timolol BID or dorzolamide-timolol BID as monotherapy (n = 101) or as adjunctive therapy to a PGA (latanoprost, bimatoprost, or travoprost) (n = 79). The studies are registered with the identifiers NCT00822081 and NCT00822055 at http://www.clinicaltrials.gov. IOP was measured at 10 a.m. (peak effect) at baseline and at months 1 and 3. Tolerability/comfort was evaluated using a patient questionnaire. There were no statistically significant between-group differences in patient demographics. Most patients were Caucasian, and the mean age was 68 years. There were also no statistically significant differences between treatment groups in baseline IOP. At month 3, the mean (SD) reduction from baseline IOP for patients on fixed-combination monotherapy was 7.7 (4.2) mmHg (32.3%) with brimonidine-timolol versus 6.7 (5.0) mmHg (26.1%) with dorzolamide-timolol (p = 0.040). The mean reduction from PGA-treated baseline IOP for patients on fixed-combination adjunctive therapy was 6.9 (4.8) mmHg (29.3%) with brimonidine-timolol versus 5.2 (3.7) mmHg (23.5%) with dorzolamide-timolol (p = 0.213). Patients on brimonidine-timolol reported less burning (p < 0.001), stinging (p < 0.001), and unusual taste (p < 0.001) than patients on dorzolamide-timolol. Fixed-combination brimonidine-timolol provided the same or greater IOP lowering compared with fixed-combination dorzolamide-timolol. Both fixed-combination medications were safe and well-tolerated. Brimonidine-timolol received higher ratings of ocular comfort than dorzolamide-timolol. The duration of the studies was 3 months, and additional studies will be needed to compare the efficacy and tolerability of brimonidine-timolol and dorzolamide-timolol during long-term treatment. Output: | {'conditions': 'Open-Angle Glaucoma|Ocular Hypertension', 'interventions': 'Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination|Drug: dorzolamide hcl 2%/ timolol maleate 0.5% fixed combination|Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy.|Drug: dorzolamide hcl 2%/timolol maleate 0.5% fixed combinatin as adjunctive to current prostaglandin therapy.'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy. Fixed combinations of 0.2% brimonidine-0.5% timolol and 2% dorzolamide-0.5% timolol are used to lower intraocular pressure (IOP). The objective of this study was to evaluate the IOP-lowering efficacy and ocular tolerability of brimonidine-timolol compared with dorzolamide-timolol when used as monotherapy or as adjunctive therapy to a prostaglandin analog (PGA) in patients with glaucoma or ocular hypertension. Pooled data analysis of two randomized, investigator-masked, 3-month, parallel-group studies with identical protocols (ten sites). In all, 180 patients with open-angle glaucoma or ocular hypertension who were in need of lower IOP received topical brimonidine-timolol BID or dorzolamide-timolol BID as monotherapy (n = 101) or as adjunctive therapy to a PGA (latanoprost, bimatoprost, or travoprost) (n = 79). The studies are registered with the identifiers NCT00822081 and NCT00822055 at http://www.clinicaltrials.gov. IOP was measured at 10 a.m. (peak effect) at baseline and at months 1 and 3. Tolerability/comfort was evaluated using a patient questionnaire. There were no statistically significant between-group differences in patient demographics. Most patients were Caucasian, and the mean age was 68 years. There were also no statistically significant differences between treatment groups in baseline IOP. At month 3, the mean (SD) reduction from baseline IOP for patients on fixed-combination monotherapy was 7.7 (4.2) mmHg (32.3%) with brimonidine-timolol versus 6.7 (5.0) mmHg (26.1%) with dorzolamide-timolol (p = 0.040). The mean reduction from PGA-treated baseline IOP for patients on fixed-combination adjunctive therapy was 6.9 (4.8) mmHg (29.3%) with brimonidine-timolol versus 5.2 (3.7) mmHg (23.5%) with dorzolamide-timolol (p = 0.213). Patients on brimonidine-timolol reported less burning (p < 0.001), stinging (p < 0.001), and unusual taste (p < 0.001) than patients on dorzolamide-timolol. Fixed-combination brimonidine-timolol provided the same or greater IOP lowering compared with fixed-combination dorzolamide-timolol. Both fixed-combination medications were safe and well-tolerated. Brimonidine-timolol received higher ratings of ocular comfort than dorzolamide-timolol. The duration of the studies was 3 months, and additional studies will be needed to compare the efficacy and tolerability of brimonidine-timolol and dorzolamide-timolol during long-term treatment. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Open-Angle Glaucoma|Ocular Hypertension', 'interventions': 'Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination|Drug: dorzolamide hcl 2%/ timolol maleate 0.5% fixed combination|Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy.|Drug: dorzolamide hcl 2%/timolol maleate 0.5% fixed combinatin as adjunctive to current prostaglandin therapy.'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
15945,
235290,
10533,
235269,
74016,
235269,
14255,
235290,
3620,
11482,
576,
4008,
1350,
63207,
235290,
13207,
15146,
17529,
12866,
3147,
99402,
235290,
13207,
15146,
8115,
235290,
121183,
13414,
235265,
139,
19549,
29862,
576,
235248,
235276,
235265,
235284,
235358,
4008,
1350,
63207,
235290,
235276,
235265,
235308,
235358,
474,
7152,
15146,
578,
235248,
235284,
235358,
12866,
3147,
99402,
235290,
235276,
235265,
235308,
235358,
474,
7152,
15146,
708,
1671,
577,
4581,
19159,
56441,
5601,
591,
112438,
846,
714,
15535,
576,
736,
3320,
729,
577,
18739,
573,
178093,
235290,
15964,
574,
43391,
578,
98535,
15227,
3966,
576,
4008,
1350,
63207,
235290,
13207,
15146,
7631,
675,
12866,
3147,
99402,
235290,
13207,
15146,
1185,
1671,
685,
1477,
90575,
689,
685,
835,
128176,
13414,
577,
476,
223553,
473,
16335,
591,
215789,
235275,
575,
6022,
675,
134329,
689,
98535,
58292,
235265,
596,
34216,
1423,
4084,
576,
1378,
74016,
235269,
71376,
235290,
80317,
235269,
235248,
235304,
235290,
10533,
235269,
14255,
235290,
3620,
6438,
675,
20745,
36894,
591,
965,
8396,
846,
878,
832,
235269,
235248,
235274,
235321,
235276,
6022,
675,
2174,
235290,
4940,
134329,
689,
98535,
58292,
1064,
1049,
575,
1476,
576,
4581,
178093,
4956,
85074,
4008,
1350,
63207,
235290,
13207,
15146,
106182,
689,
12866,
3147,
99402,
235290,
13207,
15146,
106182,
685,
1477,
90575,
591,
235254,
589,
235248,
235274,
235276,
235274,
235275,
689,
685,
835,
128176,
13414,
577,
476,
93642,
591,
102907,
715,
19829,
235269,
518,
40485,
715,
19829,
235269,
689,
9879,
715,
19829,
235275,
591,
235254,
589,
235248,
235324,
235315,
846,
714,
6438,
708,
14198,
675,
573,
95547,
128469,
235276,
235276,
235321,
235284,
235284,
235276,
235321,
235274,
578,
128469,
235276,
235276,
235321,
235284,
235284,
235276,
235308,
235308,
696,
4494,
1336,
1920,
235265,
72148,
103843,
235265,
9789,
235265,
178093,
729,
11618,
696,
235248,
235274,
235276,
476,
235265,
235262,
235265,
591,
43370,
4232,
235275,
696,
31472,
578,
696,
4063,
235248,
235274,
578,
235248,
235304,
235265,
117714,
3966,
235283,
39903,
729,
24828,
2177,
476,
7679,
43244,
235265,
2456,
1049,
793,
46527,
4937,
1865,
235290,
3620,
10216,
575,
7679,
93361,
235265,
7922,
6022,
1049,
141889,
235269,
578,
573,
2714,
3911,
729,
235248,
235318,
235321,
1658,
235265,
2456,
1049,
1170,
793,
46527,
4937,
10216,
1865,
5158,
5452,
575,
31472,
178093,
235265,
2625,
2514,
235248,
235304,
235269,
573,
2714,
591,
6896,
235275,
12025,
774,
31472,
178093,
604,
6022,
611,
8115,
235290,
121183,
1477,
90575,
729,
235248,
235324,
235265,
235324,
591,
235310,
235265,
235284,
235275,
157093,
591,
235304,
235284,
235265,
235304,
8722,
675,
4008,
1350,
63207,
235290,
13207,
15146,
17529,
235248,
235318,
235265,
235324,
591,
235308,
235265,
235276,
235275,
157093,
591,
235284,
235318,
235265,
235274,
8722,
675,
12866,
3147,
99402,
235290,
13207,
15146,
591,
235263,
589,
235248,
235276,
235265,
235276,
235310,
235276,
846,
714,
2714,
12025,
774,
93642,
235290,
63729,
31472,
178093,
604,
6022,
611,
8115,
235290,
121183,
835,
128176,
13414,
729,
235248,
235318,
235265,
235315,
591,
235310,
235265,
235321,
235275,
157093,
591,
235284,
235315,
235265,
235304,
8722,
675,
4008,
1350,
63207,
235290,
13207,
15146,
17529,
235248,
235308,
235265,
235284,
591,
235304,
235265,
235324,
235275,
157093,
591,
235284,
235304,
235265,
235308,
8722,
675,
12866,
3147,
99402,
235290,
13207,
15146,
591,
235263,
589,
235248,
235276,
235265,
235284,
235274,
235304,
846,
38586,
611,
4008,
1350,
63207,
235290,
13207,
15146,
5504,
2644,
18620,
591,
235263,
968,
235248,
235276,
235265,
235276,
235276,
235274,
823,
188961,
591,
235263,
968,
235248,
235276,
235265,
235276,
235276,
235274,
823,
578,
20386,
10122,
591,
235263,
968,
235248,
235276,
235265,
235276,
235276,
235274,
235275,
1178,
6022,
611,
12866,
3147,
99402,
235290,
13207,
15146,
235265,
27293,
235290,
121183,
4008,
1350,
63207,
235290,
13207,
15146,
4646,
573,
1809,
689,
6561,
178093,
52659,
7631,
675,
8115,
235290,
121183,
12866,
3147,
99402,
235290,
13207,
15146,
235265,
11553,
8115,
235290,
121183,
39263,
1049,
5985,
578,
1578,
235290,
68758,
840,
235265,
4062,
1350,
63207,
235290,
13207,
15146,
4956,
4871,
22658,
576,
98535,
11852,
1178,
12866,
3147,
99402,
235290,
13207,
15146,
235265,
714,
14827,
576,
573,
6438,
729,
235248,
235304,
4063,
235269,
578,
5942,
6438,
877,
614,
4880,
577,
12711,
573,
43391,
578,
15227,
3966,
576,
4008,
1350,
63207,
235290,
13207,
15146,
578,
12866,
3147,
99402,
235290,
13207,
15146,
2290,
1497,
235290,
7617,
5158,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
6047,
235290,
22675,
195971,
34181,
235371,
235302,
8329,
156246,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
4008,
1350,
63207,
5833,
79461,
235248,
235276,
235265,
235284,
152127,
13207,
15146,
9202,
607,
235248,
235276,
235265,
235308,
235358,
8115,
11137,
235371,
55031,
235292,
12866,
3147,
99402,
531,
786,
235248,
235284,
152127,
474,
7152,
15146,
9202,
607,
235248,
235276,
235265,
235308,
235358,
8115,
11137,
235371,
55031,
235292,
4008,
1350,
63207,
5833,
79461,
235248,
235276,
235265,
235284,
152127,
13207,
15146,
9202,
607,
235248,
235276,
235265,
235308,
235358,
8115,
11137,
685,
835,
128176,
577,
2474,
223553,
473,
13414,
173854,
55031,
235292,
12866,
3147,
99402,
531,
786,
235248,
235284,
152127,
13207,
15146,
9202,
607,
235248,
235276,
235265,
235308,
235358,
8115,
7887,
19003,
685,
835,
128176,
577,
2474,
223553,
473,
13414,
5294,
235270,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Research on the neural circuitry underlying fear extinction has led to the examination of D-cycloserine (DCS), a partial agonist at the N-methyl-D-aspartate receptor in the amygdala, as a method to enhance exposure therapy outcome. Preliminary results have supported the use of DCS to augment exposure therapy in adult anxiety disorders; however, no data have been reported in any childhood anxiety disorder. Thus, we sought to preliminarily examine whether weight-adjusted DCS doses (25 or 50 mg) enhanced the overall efficacy of cognitive-behavioral therapy (CBT) for pediatric obsessive-compulsive disorder (OCD). Participants were 30 youth (aged 8-17) with a primary diagnosis of OCD. The study design was a randomized, double-blinded, placebo-controlled augmentation trial examining CBT + DCS versus CBT + Placebo (15 youth per group). All patients received seven exposure and response prevention sessions paired with DCS or placebo taken 1 hour before sessions. Although not significantly different, compared with the CBT + Placebo group, youth in the CBT + DCS arm showed small-to-moderate treatment effects (d = .31-.47 on primary outcomes). No adverse events were recorded. These results complement findings in adult OCD and non-OCD anxiety disorders and provide initial support for a more extensive study of DCS augmentation of CBT among youth with OCD. Output: | {'conditions': 'Postoperative Nausea and Vomiting', 'interventions': 'Drug: Dutasteride|Drug: switch (epoetinum beta, darbepoetinum)|Drug: clopidogrel placebo'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Research on the neural circuitry underlying fear extinction has led to the examination of D-cycloserine (DCS), a partial agonist at the N-methyl-D-aspartate receptor in the amygdala, as a method to enhance exposure therapy outcome. Preliminary results have supported the use of DCS to augment exposure therapy in adult anxiety disorders; however, no data have been reported in any childhood anxiety disorder. Thus, we sought to preliminarily examine whether weight-adjusted DCS doses (25 or 50 mg) enhanced the overall efficacy of cognitive-behavioral therapy (CBT) for pediatric obsessive-compulsive disorder (OCD). Participants were 30 youth (aged 8-17) with a primary diagnosis of OCD. The study design was a randomized, double-blinded, placebo-controlled augmentation trial examining CBT + DCS versus CBT + Placebo (15 youth per group). All patients received seven exposure and response prevention sessions paired with DCS or placebo taken 1 hour before sessions. Although not significantly different, compared with the CBT + Placebo group, youth in the CBT + DCS arm showed small-to-moderate treatment effects (d = .31-.47 on primary outcomes). No adverse events were recorded. These results complement findings in adult OCD and non-OCD anxiety disorders and provide initial support for a more extensive study of DCS augmentation of CBT among youth with OCD. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Postoperative Nausea and Vomiting', 'interventions': 'Drug: Dutasteride|Drug: switch (epoetinum beta, darbepoetinum)|Drug: clopidogrel placebo'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
235280,
26012,
3320,
576,
608,
235290,
21064,
1098,
622,
84032,
576,
31572,
235290,
202252,
13414,
575,
82405,
137009,
235290,
1795,
63877,
24283,
235265,
139,
17212,
611,
573,
35544,
139975,
21476,
7440,
59195,
919,
5140,
577,
573,
14433,
576,
608,
235290,
21064,
1098,
622,
591,
163875,
823,
476,
13427,
177738,
696,
573,
646,
235290,
24725,
235290,
235299,
235290,
508,
6468,
607,
28365,
575,
573,
67066,
184553,
235269,
685,
476,
2370,
577,
14915,
12793,
13414,
17526,
235265,
58977,
3190,
791,
10005,
573,
1281,
576,
171649,
577,
35126,
12793,
13414,
575,
11787,
18579,
27242,
235289,
4187,
235269,
793,
1423,
791,
1125,
5504,
575,
1089,
20790,
18579,
24283,
235265,
8707,
235269,
783,
16561,
577,
98179,
9486,
20706,
4270,
5171,
235290,
83414,
171649,
33579,
591,
235284,
235308,
689,
235248,
235308,
235276,
11606,
235275,
20085,
573,
8691,
43391,
576,
31572,
235290,
202252,
13414,
591,
200939,
235275,
604,
82405,
137009,
235290,
1795,
63877,
24283,
591,
225845,
846,
48299,
1049,
235248,
235304,
235276,
11481,
591,
5343,
235248,
235321,
235290,
235274,
235324,
235275,
675,
476,
7920,
19491,
576,
119672,
235265,
714,
3320,
2480,
729,
476,
74016,
235269,
4199,
235290,
90376,
939,
235269,
70061,
235290,
41789,
84032,
7856,
41605,
153572,
963,
171649,
17529,
153572,
963,
232340,
591,
235274,
235308,
11481,
842,
2778,
846,
2262,
6022,
4956,
6861,
12793,
578,
3590,
24023,
16567,
44600,
675,
171649,
689,
70061,
3443,
235248,
235274,
6370,
1794,
16567,
235265,
9693,
780,
12879,
2167,
235269,
7631,
675,
573,
153572,
963,
232340,
2778,
235269,
11481,
575,
573,
153572,
963,
171649,
7762,
8588,
2301,
235290,
511,
235290,
125328,
5158,
5701,
591,
235258,
589,
954,
235304,
235274,
23192,
235310,
235324,
611,
7920,
18701,
846,
1307,
23289,
5562,
1049,
11659,
235265,
3766,
3190,
22649,
14352,
575,
11787,
119672,
578,
2173,
235290,
225845,
18579,
27242,
578,
3658,
5528,
2676,
604,
476,
978,
15752,
3320,
576,
171649,
84032,
576,
153572,
3932,
11481,
675,
119672,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
4738,
29634,
100997,
578,
144451,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
5442,
516,
1568,
914,
235371,
55031,
235292,
8266,
591,
235249,
138879,
20809,
18820,
235269,
5441,
555,
138879,
20809,
31966,
55031,
235292,
3125,
5522,
869,
3680,
70061,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy. Antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ) combinations have not been adequately studied in Asians. In this open-label, 12-week study in seven Asian areas, patients on monotherapy with angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) but not at blood pressure (BP) goal (sitting diastolic BP (SiDBP) <90 mm Hg in non-diabetics and <80 mm Hg in diabetics) were switched to losartan 50 mg/HCTZ 12.5 mg. At 4 and 8 weeks, the therapy for patients not at goal BP was titrated to losartan 100 mg/HCTZ 12.5 mg and to losartan 100 mg/HCTZ 25 mg, respectively. Data analysis included 430 patients with mean (s.d.) age 53.0 (10.1) years and 51.9% of the female gender. After 8 weeks (primary end point; titration up to losartan 100 mg/HCTZ 12.5 mg), 73.5% (95% confidence interval (CI): 69.0-77.6) of patients reached BP goal; 63.4 and 78.1% of patients reached BP goal at 4 weeks (titration up to losartan 50 mg/HCTZ 12.5 mg) and at 12 weeks (titration up to losartan 100 mg/HCTZ 25 mg). The mean changes from baseline (95% CI) in sitting systolic BP and SiDBP at 8 weeks were -16.7 (-18.0 to -15.4) mm Hg and -12.1 (-12.9 to -11.4) mm Hg, respectively. Clinical and laboratory adverse experiences (AEs) were reported in 27.5 and 21.0% of patients, respectively. Nine patients were discontinued because of drug-related clinical AEs. Switching Asian patients currently not at BP goal with ARB or ACEI monotherapy to a losartan/HCTZ combination achieved BP goal in the majority of patients. Losartan/HCTZ combinations were generally well tolerated. Output: | {'conditions': 'Gut Microbiota', 'interventions': 'Drug: nevirapine'} | 0 | Yes | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy. Antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ) combinations have not been adequately studied in Asians. In this open-label, 12-week study in seven Asian areas, patients on monotherapy with angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) but not at blood pressure (BP) goal (sitting diastolic BP (SiDBP) <90 mm Hg in non-diabetics and <80 mm Hg in diabetics) were switched to losartan 50 mg/HCTZ 12.5 mg. At 4 and 8 weeks, the therapy for patients not at goal BP was titrated to losartan 100 mg/HCTZ 12.5 mg and to losartan 100 mg/HCTZ 25 mg, respectively. Data analysis included 430 patients with mean (s.d.) age 53.0 (10.1) years and 51.9% of the female gender. After 8 weeks (primary end point; titration up to losartan 100 mg/HCTZ 12.5 mg), 73.5% (95% confidence interval (CI): 69.0-77.6) of patients reached BP goal; 63.4 and 78.1% of patients reached BP goal at 4 weeks (titration up to losartan 50 mg/HCTZ 12.5 mg) and at 12 weeks (titration up to losartan 100 mg/HCTZ 25 mg). The mean changes from baseline (95% CI) in sitting systolic BP and SiDBP at 8 weeks were -16.7 (-18.0 to -15.4) mm Hg and -12.1 (-12.9 to -11.4) mm Hg, respectively. Clinical and laboratory adverse experiences (AEs) were reported in 27.5 and 21.0% of patients, respectively. Nine patients were discontinued because of drug-related clinical AEs. Switching Asian patients currently not at BP goal with ARB or ACEI monotherapy to a losartan/HCTZ combination achieved BP goal in the majority of patients. Losartan/HCTZ combinations were generally well tolerated. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Gut Microbiota', 'interventions': 'Drug: nevirapine'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
192481,
576,
2174,
235290,
2097,
1454,
42224,
235283,
24798,
89149,
33328,
235306,
914,
11137,
13414,
575,
18439,
6022,
675,
58292,
780,
15081,
675,
67928,
57221,
689,
212318,
1477,
90575,
235265,
139,
16847,
35398,
138351,
43391,
578,
6514,
576,
1454,
42224,
235283,
24798,
89149,
33328,
235306,
914,
591,
235314,
1754,
235382,
235275,
29862,
791,
780,
1125,
44500,
14325,
575,
138847,
235265,
878,
736,
2174,
235290,
2097,
235269,
235248,
235274,
235284,
235290,
13118,
3320,
575,
6861,
18439,
4516,
235269,
6022,
611,
1477,
90575,
675,
2639,
167957,
28365,
165270,
591,
1028,
40961,
235275,
689,
2639,
167957,
235290,
232348,
33883,
59137,
591,
7551,
2437,
235275,
901,
780,
696,
5330,
5601,
591,
13436,
235275,
6789,
591,
116373,
194167,
33404,
591,
7587,
4994,
235295,
235275,
968,
235315,
235276,
4709,
73992,
575,
2173,
235290,
2197,
555,
2291,
578,
968,
235321,
235276,
4709,
73992,
575,
167805,
235275,
1049,
36429,
577,
1454,
42224,
235248,
235308,
235276,
11606,
235283,
235314,
1754,
235382,
235248,
235274,
235284,
235265,
235308,
11606,
235265,
2625,
235248,
235310,
578,
235248,
235321,
5976,
235269,
573,
13414,
604,
6022,
780,
696,
6789,
33404,
729,
6975,
9639,
577,
1454,
42224,
235248,
235274,
235276,
235276,
11606,
235283,
235314,
1754,
235382,
235248,
235274,
235284,
235265,
235308,
11606,
578,
577,
1454,
42224,
235248,
235274,
235276,
235276,
11606,
235283,
235314,
1754,
235382,
235248,
235284,
235308,
11606,
235269,
11235,
235265,
4145,
4084,
5484,
235248,
235310,
235304,
235276,
6022,
675,
2714,
591,
235256,
235265,
235258,
2330,
3911,
235248,
235308,
235304,
235265,
235276,
591,
235274,
235276,
235265,
235274,
235275,
1658,
578,
235248,
235308,
235274,
235265,
235315,
235358,
576,
573,
8914,
15408,
235265,
4660,
235248,
235321,
5976,
591,
13272,
1580,
2377,
235289,
135011,
908,
577,
1454,
42224,
235248,
235274,
235276,
235276,
11606,
235283,
235314,
1754,
235382,
235248,
235274,
235284,
235265,
235308,
11606,
823,
235248,
235324,
235304,
235265,
235308,
235358,
591,
235315,
235308,
235358,
12087,
15133,
591,
10621,
1245,
235248,
235318,
235315,
235265,
235276,
235290,
235324,
235324,
235265,
235318,
235275,
576,
6022,
8951,
33404,
6789,
235289,
235248,
235318,
235304,
235265,
235310,
578,
235248,
235324,
235321,
235265,
235274,
235358,
576,
6022,
8951,
33404,
6789,
696,
235248,
235310,
5976,
591,
487,
25770,
908,
577,
1454,
42224,
235248,
235308,
235276,
11606,
235283,
235314,
1754,
235382,
235248,
235274,
235284,
235265,
235308,
11606,
235275,
578,
696,
235248,
235274,
235284,
5976,
591,
487,
25770,
908,
577,
1454,
42224,
235248,
235274,
235276,
235276,
11606,
235283,
235314,
1754,
235382,
235248,
235284,
235308,
11606,
846,
714,
2714,
4559,
774,
31472,
591,
235315,
235308,
235358,
22788,
235275,
575,
10191,
163481,
33404,
578,
5297,
4994,
235295,
696,
235248,
235321,
5976,
1049,
728,
235274,
235318,
235265,
235324,
15958,
235274,
235321,
235265,
235276,
577,
728,
235274,
235308,
235265,
235310,
235275,
4709,
73992,
578,
728,
235274,
235284,
235265,
235274,
15958,
235274,
235284,
235265,
235315,
577,
728,
235274,
235274,
235265,
235310,
235275,
4709,
73992,
235269,
11235,
235265,
27998,
578,
17355,
23289,
12219,
591,
235280,
5305,
235275,
1049,
5504,
575,
235248,
235284,
235324,
235265,
235308,
578,
235248,
235284,
235274,
235265,
235276,
235358,
576,
6022,
235269,
11235,
235265,
32687,
6022,
1049,
69456,
1861,
576,
10471,
235290,
10451,
13324,
586,
5305,
235265,
117046,
18439,
6022,
7094,
780,
696,
33404,
6789,
675,
212318,
689,
67928,
235285,
1477,
90575,
577,
476,
1454,
42224,
235283,
235314,
1754,
235382,
11137,
14645,
33404,
6789,
575,
573,
10898,
576,
6022,
235265,
6259,
42224,
235283,
235314,
1754,
235382,
29862,
1049,
7783,
1578,
82277,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
82354,
14719,
7518,
516,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
679,
893,
5070,
622,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Patients with chronic obstructive pulmonary disease (COPD) have few options for treatment. The efficacy and safety of the phosphodiesterase-4 inhibitor roflumilast have been investigated in studies of patients with moderate-to-severe COPD, but not in those concomitantly treated with longacting inhaled bronchodilators. The effect of roflumilast on lung function in patients with COPD that is moderate to severe who are already being treated with salmeterol or tiotropium was investigated. In two double-blind, multicentre studies done in an outpatient setting, after a 4-week run-in, patients older than 40 years with moderate-to-severe COPD were randomly assigned to oral roflumilast 500 microg or placebo once a day for 24 weeks, in addition to salmeterol (M2-127 study) or tiotropium (M2-128 study). The primary endpoint was change in prebronchodilator forced expiratory volume in 1 s (FEV(1)). Analysis was by intention to treat. The studies are registered with ClinicalTrials.gov, number NCT00313209 for M2-127, and NCT00424268 for M2-128. In the salmeterol plus roflumilast trial, 466 patients were assigned to and treated with roflumilast and 467 with placebo; in the tiotropium plus roflumilast trial, 371 patients were assigned to and treated with roflumilast and 372 with placebo. Compared with placebo, roflumilast consistently improved mean prebronchodilator FEV(1) by 49 mL (p<0.0001) in patients treated with salmeterol, and 80 mL (p<0.0001) in those treated with tiotropium. Similar improvement in postbronchodilator FEV(1) was noted in both groups. Furthermore, roflumilast had beneficial effects on other lung function measurements and on selected patient-reported outcomes in both groups. Nausea, diarrhoea, weight loss, and, to a lesser extent, headache were more frequent in patients in the roflumilast groups. These adverse events were associated with increased patient withdrawal. Roflumilast improves lung function in patients with COPD treated with salmeterol or tiotropium, and could become an important treatment for these patients. Nycomed. Output: | {'conditions': 'Chronic Obstructive Pulmonary Disease', 'interventions': 'Drug: Roflumilast|Drug: Placebo'} | 1 | No | <start_of_turn>user
Your goal is to extract structured information from the user's input that matches the form described below. When extracting information please make sure it matches the type information exactly. Do not add any attributes that do not appear in the schema shown below.
```TypeScript
{ // Information on the clinical trial characteristics from the abstract
conditions: string // The condition or disease being treated in the clinical trial
drug_or_intervention: string // The drug or intervention used in the clinical trial
}
```
Please output the extracted information in JSON format. Do not output anything except for the extracted information. Do not add any clarifying information. Do not add any fields that are not in the schema. If the text contains attributes that do not appear in the schema, please ignore them. All output must be in JSON format and follow the schema specified above. Wrap the JSON in <json> tags.
Input:Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Patients with chronic obstructive pulmonary disease (COPD) have few options for treatment. The efficacy and safety of the phosphodiesterase-4 inhibitor roflumilast have been investigated in studies of patients with moderate-to-severe COPD, but not in those concomitantly treated with longacting inhaled bronchodilators. The effect of roflumilast on lung function in patients with COPD that is moderate to severe who are already being treated with salmeterol or tiotropium was investigated. In two double-blind, multicentre studies done in an outpatient setting, after a 4-week run-in, patients older than 40 years with moderate-to-severe COPD were randomly assigned to oral roflumilast 500 microg or placebo once a day for 24 weeks, in addition to salmeterol (M2-127 study) or tiotropium (M2-128 study). The primary endpoint was change in prebronchodilator forced expiratory volume in 1 s (FEV(1)). Analysis was by intention to treat. The studies are registered with ClinicalTrials.gov, number NCT00313209 for M2-127, and NCT00424268 for M2-128. In the salmeterol plus roflumilast trial, 466 patients were assigned to and treated with roflumilast and 467 with placebo; in the tiotropium plus roflumilast trial, 371 patients were assigned to and treated with roflumilast and 372 with placebo. Compared with placebo, roflumilast consistently improved mean prebronchodilator FEV(1) by 49 mL (p<0.0001) in patients treated with salmeterol, and 80 mL (p<0.0001) in those treated with tiotropium. Similar improvement in postbronchodilator FEV(1) was noted in both groups. Furthermore, roflumilast had beneficial effects on other lung function measurements and on selected patient-reported outcomes in both groups. Nausea, diarrhoea, weight loss, and, to a lesser extent, headache were more frequent in patients in the roflumilast groups. These adverse events were associated with increased patient withdrawal. Roflumilast improves lung function in patients with COPD treated with salmeterol or tiotropium, and could become an important treatment for these patients. Nycomed. Output:
<end_of_turn>
<start_of_turn>model
{'conditions': 'Chronic Obstructive Pulmonary Disease', 'interventions': 'Drug: Roflumilast|Drug: Placebo'}<end_of_turn><eos> | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
106,
1645,
108,
6922,
6789,
603,
577,
16787,
40856,
2113,
774,
573,
2425,
235303,
235256,
3772,
674,
15483,
573,
1736,
6547,
3582,
235265,
3194,
98150,
2113,
3743,
1501,
2821,
665,
15483,
573,
1916,
2113,
7880,
235265,
2390,
780,
1843,
1089,
16258,
674,
749,
780,
4824,
575,
573,
25096,
4699,
3582,
235265,
109,
1917,
188113,
109,
612,
2723,
5254,
611,
573,
13324,
7856,
10314,
774,
573,
9949,
108,
4202,
235292,
2067,
2723,
714,
4913,
689,
7197,
1855,
11017,
575,
573,
13324,
7856,
108,
10471,
235298,
483,
235298,
87893,
235292,
2067,
2723,
714,
10471,
689,
21683,
1671,
575,
573,
13324,
7856,
108,
235270,
108,
1917,
110,
5958,
5033,
573,
33378,
2113,
575,
11384,
5920,
235265,
2390,
780,
5033,
4341,
7694,
604,
573,
33378,
2113,
235265,
2390,
780,
1843,
1089,
116996,
2113,
235265,
2390,
780,
1843,
1089,
7969,
674,
708,
780,
575,
573,
25096,
235265,
1927,
573,
2793,
7744,
16258,
674,
749,
780,
4824,
575,
573,
25096,
235269,
3743,
17672,
1174,
235265,
2262,
5033,
2004,
614,
575,
11384,
5920,
578,
1611,
573,
25096,
10626,
3131,
235265,
58489,
573,
11384,
575,
968,
3327,
235313,
16323,
235265,
111,
3678,
235292,
235294,
559,
35565,
1569,
490,
575,
23135,
235290,
511,
235290,
128291,
19424,
165321,
53140,
7197,
11017,
675,
1497,
50206,
13008,
27231,
540,
3805,
235292,
1378,
192036,
13324,
21472,
235265,
139,
45161,
675,
19424,
165321,
53140,
7197,
591,
33351,
235299,
235275,
791,
2619,
4561,
604,
5158,
235265,
714,
43391,
578,
6514,
576,
573,
85774,
2908,
188854,
235290,
235310,
57221,
899,
4996,
600,
1569,
490,
791,
1125,
26344,
575,
6438,
576,
6022,
675,
23135,
235290,
511,
235290,
128291,
134973,
235269,
901,
780,
575,
1941,
92805,
500,
10775,
11017,
675,
1497,
50206,
96416,
13008,
27231,
540,
3805,
235265,
714,
4232,
576,
899,
4996,
600,
1569,
490,
611,
15382,
1411,
575,
6022,
675,
134973,
674,
603,
23135,
577,
14586,
1064,
708,
3303,
1855,
11017,
675,
1966,
16172,
561,
689,
474,
15242,
1988,
4420,
729,
26344,
235265,
878,
1378,
4199,
235290,
58122,
235269,
104221,
13991,
6438,
3015,
575,
671,
102506,
7708,
235269,
1452,
476,
235248,
235310,
235290,
13118,
2060,
235290,
473,
235269,
6022,
9964,
1178,
235248,
235310,
235276,
1658,
675,
23135,
235290,
511,
235290,
128291,
134973,
1049,
36011,
15696,
577,
19131,
899,
4996,
600,
1569,
490,
235248,
235308,
235276,
235276,
6517,
235264,
689,
70061,
3631,
476,
1744,
604,
235248,
235284,
235310,
5976,
235269,
575,
5081,
577,
1966,
16172,
561,
591,
235296,
235284,
235290,
235274,
235284,
235324,
3320,
235275,
689,
474,
15242,
1988,
4420,
591,
235296,
235284,
235290,
235274,
235284,
235321,
3320,
846,
714,
7920,
37875,
729,
2669,
575,
953,
40636,
27231,
540,
1291,
12817,
216160,
4253,
6620,
575,
235248,
235274,
485,
591,
7569,
235330,
235278,
235274,
12894,
8272,
729,
731,
15527,
577,
3516,
235265,
714,
6438,
708,
14198,
675,
27998,
132440,
235265,
9789,
235269,
1758,
128469,
235276,
235276,
235304,
235274,
235304,
235284,
235276,
235315,
604,
595,
235284,
235290,
235274,
235284,
235324,
235269,
578,
128469,
235276,
235276,
235310,
235284,
235310,
235284,
235318,
235321,
604,
595,
235284,
235290,
235274,
235284,
235321,
235265,
878,
573,
1966,
16172,
561,
2755,
899,
4996,
600,
1569,
490,
7856,
235269,
235248,
235310,
235318,
235318,
6022,
1049,
15696,
577,
578,
11017,
675,
899,
4996,
600,
1569,
490,
578,
235248,
235310,
235318,
235324,
675,
70061,
235289,
575,
573,
474,
15242,
1988,
4420,
2755,
899,
4996,
600,
1569,
490,
7856,
235269,
235248,
235304,
235324,
235274,
6022,
1049,
15696,
577,
578,
11017,
675,
899,
4996,
600,
1569,
490,
578,
235248,
235304,
235324,
235284,
675,
70061,
235265,
69083,
675,
70061,
235269,
899,
4996,
600,
1569,
490,
27930,
12188,
2714,
953,
40636,
27231,
540,
1291,
12280,
235330,
235278,
235274,
235275,
731,
235248,
235310,
235315,
48004,
591,
235263,
235322,
235276,
235265,
235276,
235276,
235276,
235274,
235275,
575,
6022,
11017,
675,
1966,
16172,
561,
235269,
578,
235248,
235321,
235276,
48004,
591,
235263,
235322,
235276,
235265,
235276,
235276,
235276,
235274,
235275,
575,
1941,
11017,
675,
474,
15242,
1988,
4420,
235265,
16651,
13194,
575,
2053,
40636,
27231,
540,
1291,
12280,
235330,
235278,
235274,
235275,
729,
9611,
575,
2145,
5452,
235265,
22174,
235269,
899,
4996,
600,
1569,
490,
1093,
26014,
5701,
611,
1156,
15382,
1411,
14548,
578,
611,
6410,
7679,
235290,
68988,
18701,
575,
2145,
5452,
235265,
100997,
235269,
158433,
235269,
5171,
4783,
235269,
578,
235269,
577,
476,
36451,
10617,
235269,
47799,
1049,
978,
19669,
575,
6022,
575,
573,
899,
4996,
600,
1569,
490,
5452,
235265,
3766,
23289,
5562,
1049,
7059,
675,
6629,
7679,
36115,
235265,
625,
559,
35565,
1569,
490,
38291,
15382,
1411,
575,
6022,
675,
134973,
11017,
675,
1966,
16172,
561,
689,
474,
15242,
1988,
4420,
235269,
578,
1538,
3831,
671,
2845,
5158,
604,
1450,
6022,
235265,
20752,
29503,
235265,
16230,
235292,
108,
107,
108,
106,
2516,
108,
26660,
33380,
2130,
777,
67822,
3740,
1504,
2759,
150120,
26995,
920,
777,
2018,
62992,
2130,
777,
55031,
235292,
625,
559,
35565,
1569,
490,
235371,
55031,
235292,
232340,
20689,
107,
1
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 118